<!DOCTYPE html><html lang="en"><head><script src="https://cdnjs.cloudflare.com/ajax/libs/js-polyfills/0.1.42/polyfill.min.js"></script><link href="https://www.hindawi.com/static/themes/hindawi/base.css" rel="stylesheet"/><meta charSet="utf-8" class="next-head"/><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"/><title class="next-head">Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway</title><link rel="canonical" href="https://www.hindawi.com/journals/ecam/2012/732578/" class="next-head"/><link rel="shortcut icon" type="image/x-icon" href="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico" class="next-head"/><meta name="title" content="Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"/><meta rel="canonical" href="https://www.hindawi.com/journals/ecam/2012/732578/"/><meta name="description" content="Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M to 40&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."/><meta property="og:url" content="https://www.hindawi.com/journals/ecam/2012/732578/"/><meta property="og:type" content="website"/><meta property="og:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta property="og:image:type" content="image/jpeg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="315"/><meta property="og:title" content="Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"/><meta name="twitter:site" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:image" content="https://images.hindawi.com/journals/ecam/ecam.banner.jpg"/><meta name="twitter:title" content="Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"/><meta property="og:description" content="Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M to 40&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."/><meta name="twitter:description" content="Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M to 40&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."/><meta name="citation_title" content="Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"/><meta name="citation_author" content="Peng, Chih-Yu"/><meta name="citation_author" content="Yang, Hui-Wen"/><meta name="citation_author" content="Chu, Yin-Hung"/><meta name="citation_author" content="Chang, Yu-Chao"/><meta name="citation_author" content="Hsieh, Ming-Ju"/><meta name="citation_author" content="Chou, Ming-Yung"/><meta name="citation_author" content="Yeh, Kun-Tu"/><meta name="citation_author" content="Lin, Yueh-Min"/><meta name="citation_author" content="Yang, Shun-Fa"/><meta name="citation_author" content="Lin, Chiao-Wen"/><meta name="citation_journal_title" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="citation_publisher" content="Hindawi"/><meta name="citation_volume" content="2012"/><meta name="citation_year" content="2012"/><meta name="citation_date" content="2012/12/18"/><meta name="citation_online_date" content="2012/12/18"/><meta name="citation_doi" content="https://doi.org/10.1155/2012/732578"/><meta name="citation_issn" content="1741-427X"/><meta name="citation_abstract" content="Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M to 40&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."/><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/ecam/2012/732578/"/><meta name="citation_pdf_url" content="https://downloads.hindawi.com/journals/ecam/2012/732578.pdf"/><meta name="citation_xml_url" content="https://downloads.hindawi.com/journals/ecam/2012/732578.xml"/><meta name="dc.creator" content="Peng, Chih-Yu"/><meta name="dc.creator" content="Yang, Hui-Wen"/><meta name="dc.creator" content="Chu, Yin-Hung"/><meta name="dc.creator" content="Chang, Yu-Chao"/><meta name="dc.creator" content="Hsieh, Ming-Ju"/><meta name="dc.creator" content="Chou, Ming-Yung"/><meta name="dc.creator" content="Yeh, Kun-Tu"/><meta name="dc.creator" content="Lin, Yueh-Min"/><meta name="dc.creator" content="Yang, Shun-Fa"/><meta name="dc.creator" content="Lin, Chiao-Wen"/><meta name="dc.title" content="Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"/><meta name="dc.description" content="Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M to 40&amp;#x2009;&lt;i&gt;&amp;#x3bc;&lt;/i&gt;M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."/><meta name="dc.publisher" content="Hindawi"/><meta name="dc.format" content="text/html"/><meta name="dc.language" content="en"/><meta name="dc.identifier" content="https://doi.org/10.1155/2012/732578"/><meta name="dc.type" content="Research Article"/><meta name="dc.date" content="2012/12/18"/><meta name="dcterms.issued" content="2012/12/18"/><meta name="prism.publicationDate" content="2012/12/18"/><meta name="prism.volume" content="2012"/><meta name="prism.section" content="Research Article"/><meta name="prism.doi" content="https://doi.org/10.1155/2012/732578"/><meta name="prism.issn" content="1741-427X"/><meta name="dc.source" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="prism.publicationName" content="Evidence-Based Complementary and Alternative Medicine"/><meta name="authors" content="Chih-Yu Peng | Hui-Wen Yang | ... | Chiao-Wen Lin"/><meta name="Author" content="Hindawi"/><meta name="robots" content="index"/><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"/><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="fbafd62a-0a4e-4f7b-a04d-56f57fa3d716"></script><link href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/basictable.css" rel="stylesheet" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.carousel.min.css" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.theme.default.min.css" media="none" class="next-head"/><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/jquery.js" class="next-head"></script><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" as="script"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/common.19957fe3.chunk.css"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js.bf2397b9.chunk.css"/><style data-styled="NQpXC gnduKR jzXSTA bNmdOy epRoim bUhGXt gjctdt jGJLow kAzjOl ivbKJD fopjOz hbVEoI khbeDd gvAGTV kNoiZu diutvq bqeMOy bMdQcY ldSkVQ cmzomn fJLQxX kuxTps prcY bJcSpM elhyhe fTkdCR jCfZqq EwsTm mkXor dULvrJ dfaOeH jOLhQl TsaZF iiusBg cqhPZs gaRePw dEfJbW eBepOs fSPaCp bVEEaH etauus ctePXh gCIfTO OGgkt dUABlg jUTgTa eujois cQgXqt ewCAZX kdvWPs hAFFGk lkWWFY ehYbwJ legory epgILe kCfRMJ bjwAQR byflLi jXeALb UVThf dDyxFF fkVFlF dzZrgS jLUVhb dVCLgr bBmZJZ ewHMLz bbzREB jknsZc eSvjPB jntdRu iySbrx bCmGAV TdHTO bmMPie fClRDD iomKnj fexZtq eGVCps mBGSe bkiEfx ztvYg cUsFHx duuwge lcOiDF gsmOCv kPshFw kRoxOt jZOxOO eHMFfo XkrFe irNWJI dMuGGA kfDwZY evMkvU fYrLtk fjviok hgKieC cIribm khHUcu exFqMv dbAANp eyHfWh cBTaXT becpDt kbSZJl jzTMLK gbrQxi hRnXob hymroZ cbcyj hmDWcT isgRZA ihmyEq itFKcQ cGuwDn jrsDZP gWTCXQ jGPvPL etzuBr gWgCNb WHkfb ibWUzs kdRRST cHatnS kxdGAZ jHPgUP fXBKFa hNPrIr bnbfTS cYsVdk inBNwS dkutRV hlGpbO filPdg ecHxGW gCiATD eEFYIL dsXEHZ iXKuYd" data-styled-version="4.4.1">
/* sc-component-id: sc-bdVaJa */
.EwsTm{height:200vh;width:100%;position:fixed;z-index:1;background:rgba(255,255,255,0.8);} .EwsTm.isHide{display:none;} @media (min-width:768px) and (max-width:991px){} @media (min-width:992px){.EwsTm{display:none;}}
/* sc-component-id: sc-htpNat */
.bUhGXt{color:black;-webkit-text-decoration:none;text-decoration:none;border-radius:5px;font-size:16px;} .bUhGXt:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-bxivhb */
.ivbKJD{display:inline-block;}
/* sc-component-id: sc-ifAKCX */
.fopjOz{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;padding:0;} .fopjOz li{padding:0 10px;} .fopjOz li a{padding:0;} .fopjOz a{-webkit-transition:border .25s ease-in-out 0s;transition:border .25s ease-in-out 0s;border-bottom:2px solid #fff;border-radius:0;} .fopjOz a:hover{border-bottom:2px solid #9b9b9b;padding-bottom:4px;} .fopjOz .active{border-bottom:2px solid #57a61e;}
/* sc-component-id: sc-EHOje */
.jOLhQl{vertical-align:middle;height:24px;}.TsaZF{vertical-align:middle;height:40px;}.iiusBg{vertical-align:middle;height:16px;}
/* sc-component-id: sc-bZQynM */
.bNmdOy{max-width:1440px;margin:0 auto;width:100%;}
/* sc-component-id: sc-htoDjs */
.khbeDd{vertical-align:middle;font-size:24px;}.gvAGTV{vertical-align:middle;font-size:9px;}.kNoiZu{vertical-align:middle;font-size:16px;}.diutvq{vertical-align:middle;font-size:22px;}.bqeMOy{vertical-align:middle;font-size:20px;}.bMdQcY{vertical-align:middle;font-size:11px;}
/* sc-component-id: sc-fjdhpX */
.jzXSTA{position:fixed;top:0;left:0;right:0;z-index:1000;background:#fff;height:70px;font-size:16px;font-weight:500;border-bottom:1px solid #e3e3e3;-webkit-transition:all 0.5s;transition:all 0.5s;} @media (max-width:991px){.jzXSTA{border-bottom:1px solid #e3e3e3;}} @media (max-width:767px){.jzXSTA{margin-bottom:70px;height:60px;}} .jzXSTA .header__padding{padding:0 20px;box-sizing:border-box;} @media (max-width:991px){.jzXSTA .header__padding{padding:0 0 0 20px;}} .jzXSTA .menu{position:fixed;top:60px;right:0;width:100%;background:white;} @media (max-width:991px){.jzXSTA .menu{z-index:2;}} @media (min-width:768px){.jzXSTA .menu{width:500px;top:70px;}} @media (min-width:991.5px){.jzXSTA .menu{display:none;}} .jzXSTA .menu ul{list-style-type:none;text-align:center;padding:0;margin:0;} @media (min-width:768px){.jzXSTA .menu ul{padding:0;border-left:1px solid #e3e3e3;}} .jzXSTA .menu ul li a{color:#4a4a4a;padding:10px;-webkit-text-decoration:none;text-decoration:none;display:block;border-bottom:1px solid #e3e3e3;} .jzXSTA .menu .button_wrap{width:90%;margin:10px auto;border-radius:5px;border-style:solid;border-width:1px;} @media (min-width:768px){.jzXSTA .menu .button_wrap{display:none;}} .jzXSTA .menu .button__publishing{background-color:#6ba439;color:#fff;border-color:#6ba439;} .jzXSTA .menu .button__login{display:none;background-color:#fff;color:#4D8A17;border-color:#e3e3e3;} .jzXSTA.headerUp{-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);}
/* sc-component-id: sc-jzJRlG */
.jGJLow{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .jGJLow a{padding:10px;} .jGJLow nav{-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} @media (max-width:991px){.jGJLow nav{display:none;}} .jGJLow nav ul{margin-right:16px;} .jGJLow nav ul li a{color:#4a4a4a;padding:10px 0px 4px;margin:0 6px;} @media (max-width:991px){.jGJLow .icon-themeable{border-left:1px solid #e3e3e3;padding:23px 20px;}} @media (max-width:767px){.jGJLow .icon-themeable{padding:18px 20px;}} @media (max-width:767.5px){.jGJLow.mobileButtonFlex{-ms-flex:0 0 51%;-webkit-flex:0 0 51%;-ms-flex:0 0 51%;flex:0 0 51%;max-width:51%;}}
/* sc-component-id: sc-cSHVUG */
.ldSkVQ{display:none;padding:0;background-color:#fff;border:none;height:59px;} @media (min-width:768px){.ldSkVQ{height:69px;}} .ldSkVQ img{box-sizing:content-box;width:28px;padding:17px 20px;} @media (min-width:768px){.ldSkVQ img{padding:22px 20px;}} @media (max-width:991px){.ldSkVQ{display:inline-block;}}
/* sc-component-id: sc-kAzzGY */
.epRoim a{display:inline-block;padding:15px 0;} @media (max-width:767px){.epRoim a{padding:10px 0;}} @media (max-width:767.5px){.epRoim.mobileLogoFlex{-ms-flex:0 0 49%;-webkit-flex:0 0 49%;-ms-flex:0 0 49%;flex:0 0 49%;max-width:49%;}}
/* sc-component-id: sc-chPdSV */
.hbVEoI{border:none;height:50px;background-color:#fff;margin:10px 0 0 17px;position:relative;} @media (max-width:991.5px){.hbVEoI{margin:0 3px 0 16px;padding:0;height:69px;}} @media (max-width:767.5px){.hbVEoI{height:59px;}} .hbVEoI img{box-sizing:content-box;} .hbVEoI .icon__cross{width:24px;height:24px;} @media (min-width:768px){.hbVEoI .icon__cross{padding:23px 20px;}} @media (min-width:992px){.hbVEoI .icon__cross{padding:0px;}}
/* sc-component-id: sc-ckVGcZ */
.gjctdt{vertical-align:middle;height:39px;} @media (max-width:401px){.gjctdt{max-width:100%;}}
/* sc-component-id: sc-jKJlTe */
.inBNwS{background-color:#0d2934;font-size:16px;position:relative;z-index:3;} @media (max-width:991px){.inBNwS{z-index:0;}}
/* sc-component-id: sc-eNQAEJ */
.dkutRV{border-bottom :1px solid;border-color:#828282;padding:29px 40px 30px 40px;} @media (min-width:992px){.dkutRV{padding:40px 40px 40px 35px;}} .dkutRV .primary__footer .mobile{display:block;} .dkutRV .primary__footer .desktop{display:none;} @media (min-width:992px){.dkutRV .primary__footer{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;}.dkutRV .primary__footer .mobile{display:none;}.dkutRV .primary__footer .desktop{display:block;}} @media (min-width:992px){.dkutRV .col5{-webkit-flex:0 0 18%;-ms-flex:0 0 18%;flex:0 0 18%;max-width:18%;}} .dkutRV address{font-style:inherit;line-height:1.5;font-size:16px;display:none;border-right:1px solid #EBEBEB;} @media (max-width:767px){.dkutRV address{border-bottom:1px solid #E3E3E3;padding-bottom:20px;}} @media (min-width:992px){.dkutRV address{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin-right:50px;}} @media (min-width:1200px){.dkutRV address{margin-right:70px;}} .dkutRV address p{margin:0;font-size:14px;} @media (max-width:767px){.dkutRV address p{text-align:center;}} @media (min-width:1200px){.dkutRV address p{font-size:16px;}} .dkutRV nav ul{list-style:none;padding:0;line-height:2;font-size:16px;margin:18px 0 0 0;} .dkutRV nav ul:first-child{margin:0;} @media (min-width:992px){.dkutRV nav ul{margin:0;}} .dkutRV nav ul li{line-height:22px;padding:5px;} .dkutRV nav ul li a{color:#d8d8d8;font-weight:500;display:block;font-size:16px;} .dkutRV nav ul li img{padding:2.5px 0 0 10px;box-sizing:content-box;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-hMqMXs */
.hlGpbO{padding-top:6px;color:#FFFFFF;font-weight:500;margin-bottom:29px;} @media (min-width:992px){.hlGpbO{-webkit-flex:0 0 25%;-ms-flex:0 0 25%;flex:0 0 25%;max-width:-webkit-fit-content;max-width:-moz-fit-content;max-width:fit-content;}}
/* sc-component-id: sc-kEYyzF */
.ecHxGW{margin-right:20px;} .ecHxGW:last-child{margin-right:0;}
/* sc-component-id: sc-kkGfuU */
.filPdg{margin-top:15px;}
/* sc-component-id: sc-iAyFgw */
.gCiATD{line-height:30px;font-size:11px;padding:10px 20px;text-align:center;} .gCiATD .textright{text-align:right;font-weight:500;} @media (max-width:767px){.gCiATD .textright{text-align:center;}} @media (min-width:992px){.gCiATD .textright{font-weight:100;}} .gCiATD a{font-size:13px;color:#fff;}
/* sc-component-id: sc-hSdWYo */
.etauus{display:inline-block;background-color:#fff;color:#4D8A17;border-color:#E3E3E3;width:auto;border-radius:5px;font-size:16px;border-width:1px;border-style:solid;} .etauus:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-eHgmQL */
.fTkdCR{font-size:22px;color:#000;} @media (min-width:767.5px){.fTkdCR{font-size:24px;}} @media (min-width:991.5px){.fTkdCR{font-size:25px;}} .fTkdCR:after{content:'';display:inline-block;margin-top:0.2em;margin-left:0.5em;}
/* sc-component-id: sc-iRbamj */
.jZOxOO{font-size:30px;font-weight:500;-webkit-letter-spacing:1px;-moz-letter-spacing:1px;-ms-letter-spacing:1px;letter-spacing:1px;line-height:1;margin-top:0;} @media (min-width:767.5px){.jZOxOO{font-size:40px;}} @media (min-width:991.5px){.jZOxOO{font-size:40px;}} .jZOxOO sup,.jZOxOO sub{vertical-align:baseline;position:relative;top:-10px;} .jZOxOO sub{top:10px;}
/* sc-component-id: sc-Rmtcm */
.hNPrIr{font-size:20px;font-weight:500;margin-top:0;margin-bottom:15px;}
/* sc-component-id: sc-bRBYWo */
.fXBKFa{display:inline-block;} @media (max-width:991.5px){.fXBKFa{width:100%;}} @media (min-width:991.5px){.fXBKFa.hide{display:none !important;}}
/* sc-component-id: sc-hzDkRC */
.bnbfTS{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;width:100%;padding:0 !important;border-top:1px solid #fff;} .bnbfTS li{width:100%;text-align:center;box-sizing:border-box;padding:17px 0px;min-height:48px;} .bnbfTS li a{display:block;} .bnbfTS .iconBorder{border-right:1px solid #fff;} .bnbfTS img{width:23px;} .bnbfTS img.socialLinkedin{width:28px;} .bnbfTS .wechat-container{position:relative;} .bnbfTS .wechat-container .addthis_inline_share_toolbox{position:absolute;top:0;left:0;width:100%;height:100%;opacity:0 !important;}
/* sc-component-id: sc-jtRfpW */
.OGgkt{background-color:#6BA439;color:#fff;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #fff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .OGgkt img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.OGgkt span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.OGgkt span.text{padding-left:20px;}}.dUABlg{background-color:#F2F2F2;color:#4A4A4A;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #E3E3E3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .dUABlg img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.dUABlg span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.dUABlg span.text{padding-left:20px;}}
/* sc-component-id: sc-kTUwUJ */
.eujois{width:20px;}
/* sc-component-id: sc-dqBHgY */
.cQgXqt{width:20px;height:16px;color:#6ba439;}
/* sc-component-id: sc-cbkKFq */
.kuxTps{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;position:fixed;top:60px;} @media (min-width:767.5px){.kuxTps{position:fixed;top:70px;}} @media (min-width:991.5px){.kuxTps{position:fixed;top:70px;}}.prcY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;top:0px;} @media (min-width:767.5px){.prcY{top:0px;}} @media (min-width:991.5px){.prcY{position:fixed;top:241px;}}
/* sc-component-id: sc-hGoxap */
.dEfJbW{position:relative;background:#007d8d;} @media (max-width:991px){.dEfJbW{z-index:2;}} @media (min-width:767.5px) and (max-width:991.5px){.dEfJbW{width:50%;}} @media (min-width:991.5px){.dEfJbW{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:1px solid white;}} .dEfJbW.isHide{display:none;} @media (min-width:991.5px){.dEfJbW.isHide{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .dEfJbW .submit__button{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;box-shadow:0 2px 4px rgba(0,0,0,.5);padding:0 20px;min-height:45px;} .dEfJbW .submit__button span.text{font-size:16px;} .dEfJbW .submit__button img{width:20px;} @media (min-width:767.5px){.dEfJbW .submit__button{min-height:58px;}.dEfJbW .submit__button img{width:22px;}} @media (min-width:991.5px){.dEfJbW .submit__button{display:none;}}
/* sc-component-id: sc-fjmCvl */
.fSPaCp{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.fSPaCp{padding:16px 20px;}} @media (min-width:991.5px){.fSPaCp{border-top:none;border-right:1px solid #fff;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.fSPaCp{padding:14.5px 20px;font-size:16px;}} .fSPaCp .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .fSPaCp.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.fSPaCp.button__active{border-right:1px solid #007f8f;}} .fSPaCp .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .fSPaCp .icon__hidden{display:none;}.bVEEaH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.bVEEaH{padding:16px 20px;}} @media (min-width:991.5px){.bVEEaH{border-top:none;border-right:0;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.bVEEaH{padding:14.5px 20px;font-size:16px;}} .bVEEaH .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .bVEEaH.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.bVEEaH.button__active{border-right:1px solid #007f8f;}} .bVEEaH .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .bVEEaH .icon__hidden{display:none;}
/* sc-component-id: sc-TFwJa */
.gCIfTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:767.5px){.gCIfTO{padding:16px 20px;}} @media (min-width:991.5px){.gCIfTO{-webkit-transition:all 0.25s;transition:all 0.25s;border-top:none;border-right:1px solid #fff;border-left:0;padding:14.5px 30px 14.5px 20px;width:calc(100% / 6);font-size:14px;}.gCIfTO:hover{background:#fff;color:#4A4A4A;}} @media (min-width:1200px){.gCIfTO{font-size:16px;}}
/* sc-component-id: sc-bHwgHz */
.ctePXh{width:18px;margin-right:-4px;} @media (min-width:991.5px){.ctePXh{width:7px;font-size:7px;}} @media (min-width:1200px){.ctePXh{width:18px;}}
/* sc-component-id: sc-krDsej */
.ewCAZX{position:absolute;top:0;width:calc(100% - 20px);right:0;bottom:0;background:#fff;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;min-height:290px;box-shadow:0 2px 4px rgba(0,0,0,0.5);} .ewCAZX.hide__submenu{-webkit-transform:translateX(100%);-ms-transform:translateX(100%);transform:translateX(100%);} @media (min-width:767.5px){.ewCAZX.hide__submenu{-webkit-transform:translateX(-200%);-ms-transform:translateX(-200%);transform:translateX(-200%);}} @media (min-width:767.5px){.ewCAZX{left:100%;width:100%;padding-top:20px;z-index:-1;min-height:375px;}} @media (min-width:991.5px){.ewCAZX{display:none;}}
/* sc-component-id: sc-dTdPqK */
.lkWWFY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;display:none;} @media (min-width:991.5px){.lkWWFY.hide__submenu{-webkit-transform:translateY(-300%);-ms-transform:translateY(-300%);transform:translateY(-300%);}} @media (min-width:991.5px){.lkWWFY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:186px;top:49px;left:0;position:absolute;right:0;background:#fff;z-index:-1;box-shadow:0 4px 6px rgba(0,0,0,0.21);}}
/* sc-component-id: sc-itybZL */
.kdvWPs{font-weight:700;border:0;color:#4A4A4A;padding:10px 0;background-color:#fff;font-size:16px;line-height:20px;} .kdvWPs:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;} @media (min-width:767.5px){.kdvWPs{display:none;}}
/* sc-component-id: sc-fzsDOv */
.hAFFGk{margin:0px 10px 2px 20px;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);display:inline-block;}
/* sc-component-id: sc-gPWkxV */
.legory{width:50%;}
/* sc-component-id: sc-jVODtj */
.epgILe{color:#007B8B;width:50%;font-size:16px;line-height:26px;margin:auto;padding:0 6%;}
/* sc-component-id: sc-kUaPvJ */
.ehYbwJ{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:50%;padding:24.5px 2% 0;-webkit-order:0;-ms-flex-order:0;order:0;} @media (min-width:1024px){.ehYbwJ{padding:24.5px 3% 0;}}
/* sc-component-id: sc-giadOv */
.eBepOs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} @media (min-width:991.5px){.eBepOs{width:calc(100% / 6);}.eBepOs:first-child{border-left:none;}}
/* sc-component-id: sc-fONwsr */
.kCfRMJ{background-color:#D8D8D8;position:absolute;left:50%;display:inline-block;height:121px;width:2px;top:33px;}
/* sc-component-id: sc-LKuAh */
.lcOiDF{padding:0;margin:10px 0 25px 0;}
/* sc-component-id: sc-iBEsjs */
.kPshFw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kPshFw:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kPshFw{margin-top:10px;}}
/* sc-component-id: sc-hzNEM */
.gsmOCv{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;background-color:#F2F2F2;padding:0 16px;} .gsmOCv.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .gsmOCv p{font-size:14px;line-height:22px;} .gsmOCv sup{margin-top:-5px;}
/* sc-component-id: sc-chbbiW */
.mBGSe{padding:0;}
/* sc-component-id: sc-kZmsYB */
.bkiEfx{font-size:14px;font-weight:700;line-height:16px;-webkit-letter-spacing:0.58px;-moz-letter-spacing:0.58px;-ms-letter-spacing:0.58px;letter-spacing:0.58px;margin:23px 0 0px !important;} @media (min-width:767.5px){.bkiEfx{margin:34px 0 0px !important;}} @media (min-width:991.5px){.bkiEfx{margin:-4px 0 0 !important;}}
/* sc-component-id: sc-RcBXQ */
.ztvYg{font-size:14px;line-height:22px;} .ztvYg a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .ztvYg a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-iSDuPN */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Bold.otf');font-weight:normal;font-style:normal;} .kRoxOt{font-weight:700;font-family:STIXGeneral-Bold;margin:19px 0 22px;font-size:25px;line-height:28px;-webkit-letter-spacing:normal;-moz-letter-spacing:normal;-ms-letter-spacing:normal;letter-spacing:normal;} @media (min-width:767.5px){.kRoxOt{font-size:25px;margin:20px 0 23px;}} @media (min-width:991.5px){.kRoxOt{font-size:30px;line-height:34px;margin:19px 0 22px;}} .kRoxOt p{margin:0;}
/* sc-component-id: sc-fZwumE */
.cUsFHx{padding:0 3px;}
/* sc-component-id: sc-fQejPQ */
.duuwge{font-size:14px;} .duuwge:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-jtRlXQ */
@font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} .exFqMv{font-family:STIXGeneral-Regular;text-align:justify;} .exFqMv a{word-break:break-all;} .exFqMv h4:first-of-type{border-top:0px solid #E3E3E3;padding-top:0;} .exFqMv h4{font-size:20px;font-family:"IBM Plex Sans",sans-serif;border-top:1px solid #E3E3E3;padding-top:23px;margin-top:15px;margin-bottom:-3px;} .exFqMv h4#abstract{margin-top:-7px;margin-bottom:-3px;} @media (min-width:767.5){.exFqMv h4#abstract{margin-top:-6px;}} @media (min-width:991.5px){.exFqMv h4#abstract{margin-top:34px;}} .exFqMv h4.references,.exFqMv h4.copyright{border-top:1px solid #E3E3E3;padding-top:23px;} .exFqMv h4.references{margin-bottom:-8px;} .exFqMv h5,.exFqMv h6{margin:22px 0;font-size:16px;word-break:break-word;} .exFqMv h6{margin:25px 0;text-align:left;} .exFqMv p{font-size:16px;word-break:break-word;} .exFqMv .floats-partial-section{border:1px solid #E3E3E3;margin:25px auto;} @media (max-width:767px){.exFqMv .floats-partial-section{margin:0 auto;overflow-x:hidden;}} .exFqMv .floats-partial-section .floats-partial-content{padding:19px 0px 19px 0px;height:254px;width:96%;overflow:hidden;margin:0 auto;position:relative;cursor:pointer;} .exFqMv .floats-partial-section .floats-partial-content table{margin:0 auto;} .exFqMv .floats-partial-section .floats-partial-content .table-group{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table object{z-index:-1;position:relative;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td{padding:4px 7px;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_left{text-align:left;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_center{text-align:center;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-content{padding:22px 0px 0 0px;height:197px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-content{padding:23px 0px 13px 0px;height:215px;}} .exFqMv .floats-partial-section .floats-partial-content:after{content:"";height:20%;position:absolute;bottom:0;right:0;left:0;background:-moz-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-webkit-gradient(linear,left top,right top,color-stop(0%,rgba(255,255,255,.7)),color-stop(56%,rgba(255,255,255,.7)),color-stop(100%,rgba(255,255,255,.7)));background:-webkit-linear-gradient(rgba(255,255,255,0) 0%,rgba(255,255,255,0.5) 30%,rgba(255,255,255,0.7) 56%,rgba(255,255,255,0.9) 75%,rgba(255,255,255,1) 100%);background:-o-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-ms-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);-webkit-filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );} .exFqMv .floats-partial-section .floats-partial-footer{background-color:#F2F2F2;border-top:1px solid #E3E3E3;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMTZweCIgaGVpZ2h0PSIycHgiIHZpZXdCb3g9IjAgMCAxNiAyIiB2ZXJzaW9uPSIxLjEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiPgogICAgPCEtLSBHZW5lcmF0b3I6IFNrZXRjaCA1My4yICg3MjY0MykgLSBodHRwczovL3NrZXRjaGFwcC5jb20gLS0+CiAgICA8dGl0bGU+SWNvbnMvQ2xvc2UgTWVudSAtPC90aXRsZT4KICAgIDxkZXNjPkNyZWF0ZWQgd2l0aCBTa2V0Y2guPC9kZXNjPgogICAgPGRlZnM+CiAgICAgICAgPHBhdGggZD0iTTUsMTMgTDE5LDEzIEMxOS41NTIyODQ3LDEzIDIwLDEyLjU1MjI4NDcgMjAsMTIgQzIwLDExLjQ0NzcxNTMgMTkuNTUyMjg0NywxMSAxOSwxMSBMNSwxMSBDNC40NDc3MTUyNSwxMSA0LDExLjQ0NzcxNTMgNCwxMiBDNCwxMi41NTIyODQ3IDQuNDQ3NzE1MjUsMTMgNSwxMyBaIiBpZD0icGF0aC0xIj48L3BhdGg+CiAgICA8L2RlZnM+CiAgICA8ZyBpZD0iUGFnZS0xIiBzdHJva2U9Im5vbmUiIHN0cm9rZS13aWR0aD0iMSIgZmlsbD0ibm9uZSIgZmlsbC1ydWxlPSJldmVub2RkIj4KICAgICAgICA8ZyBpZD0iQXJ0aWNsZS0tLU1vYmlsZS0tLUFsZ29yaXRobSIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTIwLjAwMDAwMCwgLTU0MS4wMDAwMDApIj4KICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjU3LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwLTkiPgogICAgICAgICAgICAgICAgICAgIDxnIGlkPSJHcm91cC04IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjUyLjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iR3JvdXAtNyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMC4wMDAwMDAsIDIuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iSWNvbnMvQ2xvc2UtTWVudS0tIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMy4wMDAwMDAsIDE2LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJtaW51cyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMy4wMDAwMDAsIDMuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxtYXNrIGlkPSJtYXNrLTIiIGZpbGw9IndoaXRlIj4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvbWFzaz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHVzZSBpZD0iU2hhcGUiIGZpbGw9IiMwMDAwMDAiIGZpbGwtcnVsZT0ibm9uemVybyIgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJDT0xPUi8tUHJpbWFyeS1HcmVlbiIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjNkJBNDM5IiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHJlY3QgaWQ9IlJlY3RhbmdsZSIgeD0iMCIgeT0iMCIgd2lkdGg9IjI0IiBoZWlnaHQ9IjI0Ij48L3JlY3Q+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgIDwvZz4KICAgICAgICA8L2c+CiAgICA8L2c+Cjwvc3ZnPg==') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;display:none;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{-webkit-flex:9;-ms-flex:9;flex:9;text-align:left;padding:21px 37px 10px 0px;font-size:16px;font-weight:700;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 18px 10px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 21px 10px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;padding:16px 0 16px 0;min-width:62px;max-width:62px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:16px 0 17px 0;min-width:52px;max-width:52px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:15px 0 17px 0;min-width:60px;max-width:60px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url:hover{-webkit-text-decoration:none;text-decoration:none;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{font-size:14px;padding:0px 18px 17px 22px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 15px 15px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 18px 19px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text figcaption{margin:0;padding:0;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text svg{max-width:100%;} .exFqMv ol{font-size:16px;padding-left:32px;font-family:STIXGeneral-Regular;line-height:24px;margin:15px 0;} .exFqMv ol li{margin:10px 0;padding-left:10px;word-break:normal;} .exFqMv ol li a{word-break:break-all;} .exFqMv ol li .reflinks{display:block;} .exFqMv ol li .reflinks a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .exFqMv ol li .reflinks a:hover{-webkit-text-decoration:underline;text-decoration:underline;} .exFqMv ol li .reflinks .sep{color:#000000;} .exFqMv .table-wrapper{width:auto;overflow-x:auto;} .exFqMv .table-wrapper::-webkit-scrollbar{-webkit-appearance:none;width:5px;height:5px;} .exFqMv .table-wrapper::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(0,0,0,.5);-webkit-box-shadow:0 0 1px rgba(255,255,255,.5);} @media (min-width:768px){.exFqMv .table-wrapper{overflow-x:auto;width:auto;-webkit-break-word:word-break;break-word:word-break;margin:0 auto;}} @media (min-width:992px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:1324px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:320px){.exFqMv{margin-bottom:33px;padding:0;}} @media (min-width:992px){.exFqMv{padding:0;margin-bottom:100px;}} @media (min-width:1325px){.exFqMv{margin-bottom:100px;}} .exFqMv .owl-stage{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot svg{fill:#4D8A17;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot strong{color:#4D8A17;font-weight:500;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active strong{color:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active svg{fill:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot .nowrap{white-space:nowrap;} .exFqMv .partial-carousel-dot{text-align:center;cursor:pointer;border:0;width:100px;padding-bottom:20px;background-color:#fff;display:table-cell;} .exFqMv .partial-carousel-dot:focus-visible{outline-offset:-3px;} .exFqMv .partial-carousel-dot strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel-dot strong{font-size:16px;}} .exFqMv .partial-carousel-dot img{width:90px;height:90px;border:1px solid #979797;margin:10px 0;} .exFqMv .partial-carousel-wrapper .floats-partial-middle{border-top:1px solid #e3e3e3;display:block;margin-bottom:50px;padding-top:1px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:0;}} .exFqMv .partial-carousel--single-image{overflow:hidden;text-align:center;} .exFqMv .partial-carousel--single-image img{width:100%;max-height:239px;height:auto;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image img{max-height:357px;}} @media (min-width:991.5px){.exFqMv .partial-carousel--single-image img{max-height:417px;}} .exFqMv .partial-carousel--single-image strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image strong{font-size:16px;}} .exFqMv .owl-nav,.exFqMv .owl-dots{display:none;} .exFqMv .partial-carousel-wrapper .owl-loaded{position:relative;height:auto;max-height:287px;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:287px;height:auto;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content::after,.exFqMv .owl-stage-outer::after,.exFqMv .owl-stage::after{background:transparent;} .exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:100%;overflow-x:auto;-webkit-align-items:self-start;-webkit-box-align:self-start;-ms-flex-align:self-start;align-items:self-start;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:calc(100% - 110px);}} .exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:100%;position:relative;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:20%;}} .exFqMv .floats-partial-middle{position:relative;} .exFqMv .partial-carousel-wrapper .carousel-prev{background:url('data:image/svg+xml;base64,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') no-repeat 17.5px;height:50px;width:61px;display:inline-block;border:0;border-right:1px solid #E3E3E3;padding:0;cursor:pointer;background-position-y:54.35%;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:51px;background-position-x:8px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:59px;background-position-x:16px;}} .exFqMv .partial-carousel-wrapper .carousel-next{background:url('data:image/svg+xml;base64,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') no-repeat 18.5px;height:52px;width:61px;display:inline-block;padding:0px;cursor:pointer;border:0;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:51px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:59px;}} .exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{position:absolute;right:0;bottom:-50px;height:50px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{bottom:0;}} .exFqMv .partial-carousel-wrapper .floats-partial-content{padding:12px;} .exFqMv .partial-carousel-wrapper .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{border-left:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-content{display:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-image:url(https://w2o-xhtml-parsed-preprod.s3-eu-west-1.amazonaws.com/table_thumb.svg);background-repeat:no-repeat;background-position:17px 17px;background-size:100px 70px;border-top:none;min-height:110px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{cursor:pointer;position:absolute;left:17px;top:17px;height:70px;width:100px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding-left:137px;padding-right:0px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{cursor:pointer;position:absolute;top:20px;left:135px;height:20px;width:60px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{color:black;display:block !important;-webkit-text-decoration:none;text-decoration:none;width:auto;margin-left:140px;margin-right:20px;padding:0px 0px 15px 0px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .minimize_btn{display:none !important;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .expand_btn{display:none !important;} @media (max-width:567px){.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-size:60px 45px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{height:45px;width:60px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding:30px 0px 15px 95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{top:30px;left:95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{margin:0px 20px;}} .exFqMv .owl-item{overflow-y:hidden;margin-bottom:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;} .exFqMv .supplementary--docs{display:-ms-flexbox;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;padding-left:2em;} @media (min-width:767.5px){.exFqMv .supplementary--docs{padding-left:1em;}} .exFqMv .supplementary--docs li{-ms-flex:0 0 100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (min-width:991.5px){.exFqMv .supplementary--docs li{-ms-flex:0 0 50%;-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} .exFqMv .supplementary--docs li a::after{content:'';background :url(data:image/svg+xml;base64,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) no-repeat 5px;padding-right:35px;background-size:14px;} .exFqMv .dataset-section .supplementary--dpis-desc{padding-left:19px;} .exFqMv .dataset-section .supplementary--dpis-desc p{margin:10px 0;} .exFqMv .table-group.fixed-width,.exFqMv .table-group.sidewaystable{min-width:auto;} .exFqMv .noliststyle{padding-left:1em;} .exFqMv .noliststyle li{padding-left:0;} .exFqMv .xml-content > hr{display:none;} .exFqMv sup,.exFqMv sub{vertical-align:baseline;position:relative;top:5px;} .exFqMv sup{top:-5px;} @media (min-width:767.5px){.exFqMv a{position:relative;}} .exFqMv a div.tooltip{cursor:auto;position:absolute;width:280px;background:#fff;border:1px solid #adadad;padding:20px;margin:0;display:none;z-index:2;color:#000;} @media (min-width:767.5px){.exFqMv a div.tooltip{width:400px;}} @media (min-width:991.5px){.exFqMv a div.tooltip{width:572px;}} .exFqMv a div.tooltip .cross{position:absolute;right:10px;top:10px;display:block;height:14px;width:14px;cursor:pointer;} .exFqMv a div.tooltip ol{margin:0;padding:0 0 10px 20px;} .exFqMv a div.tooltip ol li{text-align:left;margin:0;} .exFqMv a div.tooltip.left{left:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.left{left:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.left{left:-100px;}} .exFqMv a div.tooltip.right{right:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.right{right:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.right{right:-100px;}} .exFqMv a div.tooltip a.seeRef{padding-left:30px;} .exFqMv .gloss-abbr tr td:first-child{white-space:nowrap;} .exFqMv table.algorithm td{word-break:keep-all;} .exFqMv h4#copyright + p a{word-break:break-word;}
/* sc-component-id: sc-bGbJRg */
.dVCLgr{width:100%;} @media (min-width:991.5px){.dVCLgr{width:19%;}} @media (min-width:1280px){.dVCLgr{width:24%;max-width:350px;}} .dVCLgr p{border:1px solid #E3E3E3;}
/* sc-component-id: sc-bEjcJn */
.jLUVhb{-webkit-flex:1 0 30%;-ms-flex:1 0 30%;flex:1 0 30%;list-style:none;padding:0;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media (min-width:320px) and (max-width:991.5px){.jLUVhb{position:fixed;width:100%;z-index:2;margin:0;margin-top:50px;top:169px;max-height:calc(100vh - 165px);overflow-y:auto;}} @media (min-width:767.5px) and (max-width:991.5px){.jLUVhb{top:179px;}} @media (min-width:991.5px) and (max-width:1200px){.jLUVhb{max-width:354px;-webkit-flex:1 0 20%;-ms-flex:1 0 20%;flex:1 0 20%;}} @media (min-width:1200px){.jLUVhb{-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;max-width:354px;}} .jLUVhb p{margin:0;padding:10px 0;font-size:16px;font-weight:700;line-height:24px;display:none;} @media (min-width:991.5px){.jLUVhb p{display:block;padding:10px 20px;border:1px solid #E3E3E3;border-bottom:0;}} .jLUVhb.links__hidden{display:none;} @media (min-width:991.5px){.jLUVhb.links__hidden{display:block;}} .jLUVhb.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);} @media (min-width:768px){.jLUVhb.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.jLUVhb.translate{-webkit-transform:none;-ms-transform:none;transform:none;}.jLUVhb.translate #leftSectionMenu{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: sc-ePZHVD */
.ewHMLz{color:#4A4A4A;}
/* sc-component-id: sc-likbZx */
.bBmZJZ{font-size:16px;font-weight:500;line-height:20px;color:#4A4A4A;border:1px solid #E3E3E3;border-bottom:0;background-color:#f2f2f2;display:list-item;} @media (min-width:991px){.bBmZJZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.bBmZJZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .bBmZJZ:last-child{border-bottom:1px solid #E3E3E3;} .bBmZJZ a{display:block;padding:10px 20px;}
/* sc-component-id: sc-eKZiaR */
.dzZrgS{position:fixed;width:100%;height:50px;color:#4D8A17;background-color:#F2F2F2;border:none;font-size:16px;line-height:18px;font-weight:500;z-index:2;top:170px;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;text-align:left;border-top:1px solid #FFFFFF;} @media (min-width:320px) and (max-width:991.5px){.dzZrgS{padding-left:15px;border-bottom:4px solid #FFFFFF;}.dzZrgS.is-open{border-bottom:4px solid #F2F2F2;}} @media (min-width:767.5px){.dzZrgS{top:179px;}} @media (min-width:991.5px){.dzZrgS{display:none;}} .dzZrgS .icon__dots{cursor:pointer;-webkit-transform:rotate(90deg) translateY(8px);-ms-transform:rotate(90deg) translateY(8px);transform:rotate(90deg) translateY(8px);margin-right:15px;} @media (min-width:991.5px){.dzZrgS .icon__dots{padding-right:20px;margin-bottom:2px;-webkit-transform:none;-ms-transform:none;transform:none;}} .dzZrgS.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);top:170px;} @media(min-width:991.5px){.dzZrgS.translate{-webkit-transform :translateY(-130px) rotate(90deg);-ms-transform :translateY(-130px) rotate(90deg);transform :translateY(-130px) rotate(90deg);}}
/* sc-component-id: sc-jrIrqw */
.eHMFfo{padding:0;margin:20px 0;} .eHMFfo span{font-size:14px;} .eHMFfo span.isHide{display:none;} .eHMFfo span i{font-style:italic;} .eHMFfo span i.isHide{display:none;}
/* sc-component-id: sc-hjRWVT */
.irNWJI{width:16px;margin:0 2px 2px;}
/* sc-component-id: sc-iQtOjA */
.kfDwZY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kfDwZY:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kfDwZY{margin-top:5px;}}
/* sc-component-id: sc-fHxwqH */
.dMuGGA{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA p:first-child{margin-top:15px;} .dMuGGA p{font-size:14px;line-height:23px;display:block;} .dMuGGA sup{margin-top:-5px;}
/* sc-component-id: sc-cEvuZC */
.XkrFe{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;} .XkrFe.hr__author{margin-bottom:12px;}
/* sc-component-id: sc-cBdUnI */
@media (min-width:320px) and (max-width:991.5px){.hRnXob{display:none;}} @media (min-width:991.5px){.hRnXob{z-index:1;}}
/* sc-component-id: sc-exkUMo */
.hymroZ{background-color:#6ba339;color:#ffffff;display:none;} .hymroZ span.text{padding-left:20px;} @media (min-width:991px){.hymroZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hymroZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-kcDeIU */
.cbcyj{background-color:#f2f2f2;color:#4a4a4a;display:none;} .cbcyj span.text{padding-left:20px;} @media (min-width:991.5px) and (max-width:1279.5px){.cbcyj{display:none !important;}} @media (min-width:991px){.cbcyj{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.cbcyj:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.cbcyj.hide{display:none !important;}}
/* sc-component-id: sc-BngTV */
.hmDWcT{background-color:#f2f2f2;color:#4a4a4a;display:none;} .hmDWcT span.text{padding-left:20px;} @media (min-width:1279.5px){.hmDWcT{display:none !important;}} @media (min-width:991px){.hmDWcT{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hmDWcT:hover{background-color :#5D9230;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.hmDWcT.hide{display:none !important;}}
/* sc-component-id: sc-hBbWxd */
.kdRRST{background-color:#f2f2f2;border-top:1px solid #ffffff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:14px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;padding:20px 55px 20px 25px;} @media (max-width:1279.5px){.kdRRST{padding-right:20px;}} @media (max-width:991.5px){.kdRRST{display:none;}}
/* sc-component-id: sc-dyGzUR */
.cHatnS div{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} .cHatnS div:last-of-type{padding-top:20px;} .cHatnS span{color:#4F4F4F;font-size:20px;font-weight:700;line-height:26px;}
/* sc-component-id: sc-drKuOJ */
.kxdGAZ{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;height:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .kxdGAZ span{padding-top:15px;}
/* sc-component-id: sc-cTjmhe */
@media (min-width:991.5px){.ihmyEq{width:100%;z-index:1;}}
/* sc-component-id: sc-cugefK */
.itFKcQ{background-color:#F2F2F2;color:#4A4A4A;border-top:1px solid #FFFFFF;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:991px){.itFKcQ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.itFKcQ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.itFKcQ.hide{display:none !important;}} .itFKcQ.active .icon-themeable{-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-fnwBNb */
.etzuBr{display:none;}
/* sc-component-id: sc-iNhVCk */
.gWgCNb{background-color:#f2f2f2;border-radius:0;border-top:1px solid #e3e3e3;font-size:16px;color:#4a4a4a;font-weight:500;padding:11px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} @media (min-width:991px){.gWgCNb{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.gWgCNb:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-eAKXzc */
.WHkfb{-webkit-flex:1 0 90%;-ms-flex:1 0 90%;flex:1 0 90%;padding-left:50px;} @media (min-width:767.5px){.WHkfb{padding-left:93px;}} @media (min-width:991.5px){.WHkfb{padding-left:50px;}}
/* sc-component-id: sc-bfYoXt */
.cGuwDn{width:20px;height:24px;}
/* sc-component-id: sc-gbOuXE */
.jGPvPL{width:22px;height:21px;padding:2px;}
/* sc-component-id: sc-dRFtgE */
.jrsDZP{-webkit-flex:1 0 80%;-ms-flex:1 0 80%;flex:1 0 80%;padding-left:26px;} @media (min-width:767.5px){.jrsDZP{padding-left:69px;}} @media (min-width:991.5px){.jrsDZP{padding-left:20px;}} @media (min-width:991.5px) and (max-width:1279.5px){.jrsDZP{display:none;}}
/* sc-component-id: sc-gkFcWv */
.gWTCXQ{display:none;} @media (min-width:991.5px){.gWTCXQ{padding-left:20px;max-width:100px;display:inline;}} @media (min-width:1279.5px){.gWTCXQ{display:none;}}
/* sc-component-id: sc-hUfwpO */
.jHPgUP{width:100%;border-left:1px solid #f2f2f2;border-right:1px solid #f2f2f2;border-bottom:none;cursor:pointer;} .jHPgUP li{background-color:#f2f2f2;} @media (min-width:991px){.jHPgUP li{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.jHPgUP li:hover{background-color :#ffffff;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .jHPgUP h3{display:none;}
/* sc-component-id: sc-imABML */
.ibWUzs{background-color:#f2f2f2;color:#4a4a4a;display:block;border-top:1px solid #ffffff;border-radius:0;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} .ibWUzs .right__icon{padding:0;height:16px;width:20px;} @media (min-width:991px){.ibWUzs{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.ibWUzs:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.ibWUzs.hide{display:none !important;}}
/* sc-component-id: sc-cjHlYL */
.mkXor{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:25%;float:right;margin-top:-49px;} @media (max-width:374px){.mkXor{width:26.5%;}} @media (min-width:992px){.mkXor{display:none;}}
/* sc-component-id: sc-dRaagA */
.dULvrJ{background-color:#6ba339;color:white;-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;z-index:100;padding:14px 16px 10px 19px;border-radius:0px;border-bottom:1px solid #ffffff;} @media (min-width:320px) and (max-width:767px){.dULvrJ{border-bottom:none;padding:16px 16px 14px 16px;font-size:14px;}.dULvrJ .article_toolbar_icon{display:none;}}
/* sc-component-id: sc-fEUNkw */
.dfaOeH{margin-right:16px;width:24px;height:24px;}
/* sc-component-id: sc-dREXXX */
.cqhPZs{width:16px;height:auto;float:right;} @media (min-width:767.5px){.cqhPZs{width:24px;height:24px;}}
/* sc-component-id: sc-nrwXf */
.byflLi{font-size:14px;padding:16px 20px 24px;} @media (max-width:991px){.byflLi{display:none;}}
/* sc-component-id: sc-eitiEO */
.jXeALb{font-size:14px;} .jXeALb:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-bhlBdH */
.UVThf{font-size:14px;font-weight:bold;}
/* sc-component-id: sc-kDhYZr */
.iySbrx{margin:35px 0 0;display:none;} @media(max-width:767px){.iySbrx.mobile_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.iySbrx.row2{margin:15px 0 0;}} @media(min-width:768px){.iySbrx.desktop_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} @media (min-width:991.5px){.iySbrx{margin:0;}}
/* sc-component-id: sc-sPYgB */
.bCmGAV{width:15px;border-bottom:1px solid #E0E0E0;} @media(max-width:767px){.bCmGAV.row2_edge_left{-webkit-flex-basis:10%;-ms-flex-preferred-size:10%;flex-basis:10%;}.bCmGAV.row2_edge_right{-webkit-flex-basis:30%;-ms-flex-preferred-size:30%;flex-basis:30%;}}
/* sc-component-id: sc-dHIava */
.TdHTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;border-bottom:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4D8A17 !important;} .TdHTO:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.TdHTO{width:215px;}} .TdHTO:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}.bmMPie{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4A4A4A !important;} .bmMPie:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.bmMPie{width:215px;}} .bmMPie:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}
/* sc-component-id: sc-bSbAYC */
.fClRDD{border-width:1px;border-style:solid;border-color:#007B8B;background:rgba(0,123,139,0.05);padding:25px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:30px;}
/* sc-component-id: sc-guztPN */
.fexZtq{display:block;margin-left:15px;} @media(min-width:768px){.fexZtq{margin-left:30px;}} .fexZtq br{content:"";display:block;margin-bottom:16px;}
/* sc-component-id: sc-cFlXAS */
.iomKnj{font-family:STIXGeneral;font-size:30px;width:37px;height:37px;-webkit-flex:1 0 37px;-ms-flex:1 0 37px;flex:1 0 37px;border-radius:50%;background:#3396A3;color:#FFFFFF;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-weight:bold;} @media(min-width:768px){.iomKnj{font-size:40px;width:48px;height:48px;-webkit-flex:1 0 48px;-ms-flex:1 0 48px;flex:1 0 48px;}}
/* sc-component-id: sc-OxbzP */
.eEFYIL{width:100%;height:auto;background-color:#4A4A4A;font-family:'IBM Plex Sans',sans-serif;font-size:14px;font-weight:500;color:#fff;padding:15px 20px;line-height:20px;position:fixed;bottom:0px;z-index:3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-transition:-webkit-transform .25s;-webkit-transition:transform .25s;transition:transform .25s;} .eEFYIL a{color:#7ED321;} .eEFYIL p{display:inline;margin:0;} .eEFYIL.hideBanner{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);}
/* sc-component-id: sc-bYnzgO */
.dsXEHZ{background:transparent;border:none;height:20px;width:20px;margin-left:20px;padding:0;cursor:pointer;}
/* sc-component-id: sc-cPuPxo */
.iXKuYd{min-width:20px;height:20px;}
/* sc-component-id: baseContent__Main-sc-134g3di-2 */
.cmzomn{margin-top:140px;} @media (min-width:767.5px){.cmzomn{margin-top:85px;}} @media (min-width:991.5px){.cmzomn{margin-top:70px;min-height:calc(100vh - 334px);}}
/* sc-component-id: threeColumn__ThreeColumnWrapper-sc-1bf4078-0 */
.dDyxFF{width:100%;} @media only screen and (min-width:992px){.dDyxFF{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;padding:0 20px;max-width:1440px;margin:0 auto;}} @media (min-width:991.5px) and (max-width:1100.5px){.dDyxFF .partenership__collabText{font-size:12px;}} @media (min-width:1100.5px) and (max-width:1200.5px){.dDyxFF .partenership__collabText{font-size:14px;}} @media (min-width:991.5px) and (max-width:1071.5px){.dDyxFF .partenership__logoWrapper img{margin-left:20px;margin-bottom:10px;}.dDyxFF .partenership__logoWrapper img:last-child{margin-left:0;margin-bottom:0;}} @media (max-width:1150px){.dDyxFF .journal-metrics-container{display:none;}.dDyxFF .journal_report_link-border-helper{display:none;}}
/* sc-component-id: threeColumn__LeftWrapper-sc-1bf4078-1 */
@media only screen and (min-width:992px){.fkVFlF{width:20%;}} @media only screen and (min-width:1280px){.fkVFlF{width:25%;}}
/* sc-component-id: threeColumn__RightWrapper-sc-1bf4078-2 */
.jzTMLK{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media only screen and (min-width:992px){.jzTMLK{width:20%;margin-bottom:60px;}.jzTMLK.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media only screen and (min-width:1280px){.jzTMLK{width:25%;}}
/* sc-component-id: threeColumn__ContentWrapper-sc-1bf4078-3 */
.bbzREB{margin:0 20px;overflow:hidden;} @media only screen and (min-width:992px){.bbzREB{width:calc(60% - 40px);}} @media only screen and (min-width:1280px){.bbzREB{width:calc(50% - 40px);}}
/* sc-component-id: threeColumn__Content-sc-1bf4078-4 */
.jknsZc{margin:0 auto;overflow:hidden;} @media only screen and (min-width:768px){.jknsZc{max-width:688px;}} @media only screen and (min-width:992px){.jknsZc{max-width:100%;}} @media only screen and (min-width:1075px){.jknsZc{max-width:572px;}}
/* sc-component-id: article__BaseStyle-sc-10qhnp8-0 */
.gnduKR{width:100%;margin-top:170px;} @media (min-width:767.5px){.gnduKR{margin-top:179px;}} @media (min-width:991.5px){.gnduKR{margin-top:180px;min-height:840px;}}
/* sc-component-id: article__StickyStyle-sc-10qhnp8-1 */
.fJLQxX{width:100%;max-width:1440px;z-index:3;-webkit-transition:all 0.5s;transition:all 0.5s;} .fJLQxX.translate{-webkit-transform:translateY(-120px);-ms-transform:translateY(-120px);transform:translateY(-120px);} @media (min-width:767.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: article__SubtitleStyled-sc-10qhnp8-2 */
.elhyhe{background-color:#007b8b;opacity:0.8;color:#fff;margin-bottom:0;margin-top:0;padding:17px 0 17px 20px;line-height:23px;height:60px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:20px;font-weight:500;} @media (min-width:767.5px){.elhyhe{line-height:26px;}} @media (min-width:991.5px){.elhyhe{line-height:50px;padding:5px 0 5px 20px;height:60px;}}
/* sc-component-id: article__JournalMenuTitle-sc-10qhnp8-3 */
.jCfZqq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:16px;font-weight:500;line-height:20px;height:50px;width:100%;background-color:#007b8b;color:#fff;text-align:left;padding-left:14px;padding-right:0;border:0;border-top:1px solid #fff;} .jCfZqq span{font-size:24px;padding-right:14px;} @media (min-width:991.5px){.jCfZqq{display:none;}}
/* sc-component-id: article__WhiteWrapper-sc-10qhnp8-5 */
.bJcSpM{background-color:#fff;display:block;position:relative;} .bJcSpM h1,.bJcSpM h2{color:#fff;} .bJcSpM h2{font-size:20px;} @media (min-width:767.5px){.bJcSpM h2{font-size:25px;}} .bJcSpM h1{font-size:20px;} @media (min-width:767.5px){.bJcSpM h1{font-size:24px;}} @media (min-width:991.5px){.bJcSpM h1{font-size:40px;}}
/* sc-component-id: articleContent__ArticleContentsWrapper-sc-2yl9jy-0 */
.eSvjPB{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} .eSvjPB .author__editor--hr{display:block;}
/* sc-component-id: articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 */
.jntdRu{width:100%;} @media (max-width:991.5px){.jntdRu{margin-top:52px;}} .jntdRu p{margin:12px 0;line-height:20px;} .jntdRu .articlecontent__alignment{width:100%;min-width:306px;padding-left:7px;padding-right:7px;} @media (min-width:346px){.jntdRu .articlecontent__alignment{padding-left:20px;padding-right:20px;}} @media (min-width:767.5px){.jntdRu .articlecontent__alignment{width:543px;margin:auto;padding-left:0px;padding-right:0px;}} @media (min-width:991.5px){.jntdRu .articlecontent__alignment{max-width:612px;width:75%;margin:inherit;margin-left:50px;padding-left:20px;padding-right:20px;}} @media (min-width:1100px){.jntdRu .articlecontent__alignment{margin-left:118px;}} .jntdRu .article__title{padding-bottom:12px;} @media (min-width:767.5px){.jntdRu .article__title{padding-bottom:15px;}} .jntdRu .article__summary{padding-bottom:65px;} @media (min-width:991.5px){.jntdRu .article__summary{padding-bottom:75px;}} @media (min-width:767.5px){.jntdRu #vjs_video_3 button{-webkit-transform:none;-ms-transform:none;transform:none;left:40%;margin-top:0;}} .jntdRu .video-js .vjs-big-play-button{top:calc(50% - 22.5px);left:calc(50% - 50px);} .jntdRu .video-js{margin:20px 0;} .jntdRu a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .jntdRu a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: articleContent__ArticleWrapper-sc-2yl9jy-2 */
.eGVCps{background-position:0px 0px;background-origin:content-box;background-size:99%;margin-top:50px;}
/* sc-component-id: articleContent__EditorWrapper-sc-2yl9jy-3 */
.evMkvU{padding:0;}
/* sc-component-id: articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 */
.fjviok{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:15px 0 30px;border-bottom:1px solid #E3E3E3;} @media (min-width:767.5px){.fjviok{border-top:1px solid #E3E3E3;margin:20px 0 30px;}}
/* sc-component-id: articleContent__PublcationCol-sc-2yl9jy-5 */
.hgKieC{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;max-width:100%;border-right:1px solid #E3E3E3;padding:5px 0 15px;} @media (min-width:767.5px){.hgKieC{padding:5px 0;}} .hgKieC.notPublished{display:none;} @media (min-width:767.5px){.hgKieC.notPublished{display:block;}} @media (max-width:767.5px){.hgKieC.isPublished{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.hgKieC.isPublished span:first-child::after{content:':';padding-right:3px;}} .hgKieC:last-child{border-right:none;}
/* sc-component-id: articleContent__PublicationField-sc-2yl9jy-6 */
.cIribm{display:block;text-align:center;font-size:14px;font-weight:700;}
/* sc-component-id: articleContent__PublicationValue-sc-2yl9jy-7 */
.khHUcu{display:block;text-align:center;font-size:14px;}
/* sc-component-id: articleContent__TextWrapper-sc-2yl9jy-8 */
.fYrLtk{margin:-7px 0 -5px;font-size:14px;}
/* sc-component-id: biblio__Wrapper-sc-1nou1lz-0 */
.eyHfWh{position:relative;} .eyHfWh.hide{display:none;} .eyHfWh hr{position:absolute;left:0;right:0;top:-30px;border-top:1px solid #E3E3E3;border-bottom:0;}.cBTaXT.hide{display:none;} .cBTaXT hr{display:none;}
/* sc-component-id: biblio__BiblioWrapper-sc-1nou1lz-1 */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/_/hindawi-ui/fonts/STIXGeneral-Regular.otf');} .kbSZJl{padding:0 20px 20px;} .kbSZJl .bib__image{display:none;} .kbSZJl .bib__title{font-size:20px;} .kbSZJl .bib__name{font-size:18px;font-family:'STIXGeneral-Bold',serif !important;color:rgb(74,74,74);font-weight:700;} .kbSZJl .bib--split .bib__link .bib__info,.kbSZJl .bib--split .bib__link.bib__link--image .bib__info,.kbSZJl [class*='bib--txt'] .bib__link .bib__info,.kbSZJl [class*='bib--txt'] .bib__link.bib__link--image .bib__info{padding:10px 0 !important;} .kbSZJl .bib__author{font-size:14px;line-height:22px;color:rgb(132,132,132);margin-top:3px;margin-bottom:0px;margin-right:20px;opacity:1;font-family:'IBM Plex Sans',sans-serif;font-weight:500;} .kbSZJl #biblio_sidebar .bib__link{border-top:1px solid rgb(227,227,227) !important;padding-top:5px !important;padding-bottom:5px !important;} .kbSZJl #biblio_sidebar .bib__link:first-child{border-top:0 !important;padding-top:0 !important;} .kbSZJl #biblio_sidebar .bib__link:first-child .bib__info{padding-top:0 !important;} .kbSZJl #biblio_widget .bib--split .bib__link .bib__info,.kbSZJl #biblio_widget .bib--split .bib__link.bib__link--image .bib__info{padding:10px 15px 10px 0 !important;} @media (min-width:767.5px){.kbSZJl{padding:0 40px 20px;}} @media (min-width:991.5px){.kbSZJl{padding:0 20px;}}
/* sc-component-id: biblio__H4-sc-1nou1lz-2 */
.becpDt{font-size:20px;font-family:'IBM Plex Sans';color:#000;font-weight:600;margin-top:34px;margin-bottom:18px;padding:0 20px;}
/* sc-component-id: journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 */
.gbrQxi{display:none;} @media (min-width:991.5px){.gbrQxi{display:block;}.gbrQxi .article_top_toolbar{top:110px;z-index:-100;}.gbrQxi .article_top_toolbar .pdf_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.gbrQxi .article_top_toolbar .ref_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .gbrQxi .article_toolbar_views{margin-top:-58px;display:block;text-align:right;}
/* sc-component-id: journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 */
@media (min-width:991.5px){.isgRZA .article_bottom_toolbar{top:292px;z-index:-10;}}
/* sc-component-id: journal_article__BreadCrumbStyle-sc-12fk6zy-2 */
@media (min-width:991.5px){.bjwAQR{padding:16px 20px 24px;height:60px;}}
/* sc-component-id: journal_article__ArticleBaseStyle-sc-12fk6zy-3 */
.NQpXC .content,.NQpXC .contentWrapper{overflow:visible;}
/* sc-component-id: journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 */
.cYsVdk{max-width:350px;} @media (max-width:991.5px){.cYsVdk{display:none !important;}}
/* sc-component-id: journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 */
.dbAANp{background-color:#f5f5f5;padding:15px 20px 24px 20px;margin-top:2px;margin-bottom:20px;} @media (min-width:991.5px){.dbAANp{margin-top:-64px;margin-bottom:40px;}} .dbAANp .hrTitleRef{padding:0;margin-top:0;font-family:'IBM Plex Sans',sans-serif;} .dbAANp #biblio_widget{padding:0;}</style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-fjdhpX jzXSTA"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-kAzzGY epRoim mobileLogoFlex _1fpqArXPCxgnlv2rXZC2sl _1SoDWGr_FVsil9klRfjnhb"><a class="sc-htpNat bUhGXt link" href="/" aria-label="Home"><img alt="logo" src="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg" class="sc-ckVGcZ gjctdt"/></a></div><div class="sc-jzJRlG jGJLow mobileButtonFlex _2v1j-tLx3hx0tgKcpPzH6B _3wm8FgzqRuRWouJG31YgKx E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kpOJdX kAzjOl"><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-chPdSV hbVEoI icon__search" aria-label="Search"><span class="sc-htoDjs khbeDd icon__search icon-colored _3hSk3ArgsWMFh5QJIGblNr icon-themeable" title="" font-size="24"></span></button><button aria-label="Hamburger Menu" class="sc-cSHVUG ldSkVQ"><span class="sc-htoDjs khbeDd hamburger icon-colored _20YUA8q5mREEBfJm8VsdXV icon-themeable" title="" font-size="24"></span></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cmzomn  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-3 NQpXC"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-cbkKFq kuxTps article__StickyStyle-sc-10qhnp8-1 fJLQxX"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 bJcSpM" href="/journals/ecam/" aria-label=""><h2 class="sc-eHgmQL fTkdCR article__SubtitleStyled-sc-10qhnp8-2 elhyhe _1ZrXcsbATVL_kHOpFAan9k">Evidence-Based Complementary and Alternative Medicine</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 jCfZqq journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu</button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-cjHlYL mkXor"><a class="sc-htpNat bUhGXt link sc-dRaagA dULvrJ article-toolbar-link" href="https://downloads.hindawi.com/journals/ecam/2012/732578.pdf" aria-label="" download=""><img alt=" " class="sc-EHOje jOLhQl sc-fEUNkw dfaOeH article_toolbar_icon" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/>PDF<img alt=" " class="sc-EHOje jOLhQl sc-dREXXX cqhPZs" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><nav id="journal__nav" class="sc-hGoxap dEfJbW article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl fSPaCp journalNavCheck" color="">Journal overview<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/ecam/contents/year/2022/" aria-label="Table of Contents">Table of Contents</a><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl bVEEaH journalNavCheck" color="">Special Issues<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-jtRfpW OGgkt submit__button journalNavCheck" href="https://review.hindawi.com/submit?journal=ecam" aria-label="" target="" id=""><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ jUTgTa" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Submit</span></span><span class="sc-htoDjs kNoiZu sc-dqBHgY cQgXqt fileArrow icon-colored undefined icon-themeable" title="" font-size="16"></span></a><div class="sc-krDsej ewCAZX hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-itybZL kdvWPs journalSubmenuCheck"><span class="sc-htoDjs gvAGTV sc-fzsDOv hAFFGk journalSubmenuCheck icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><div class="sc-dTdPqK lkWWFY hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-kUaPvJ ehYbwJ"><div class="sc-gPWkxV legory"></div><div class="sc-gPWkxV legory"></div></div><div class="sc-jVODtj epgILe"></div><span class="sc-fONwsr kCfRMJ"></span></div></nav></div><div class="sc-nrwXf byflLi breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-2 bjwAQR article"><a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/" aria-label="Evidence-Based Complementary and Alternative Medicine">Evidence-Based Complementary and Alternative Medicine</a> / <a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/ecam/contents/year/2012/" aria-label="2012">2012</a> / <span class="sc-bhlBdH UVThf">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 dDyxFF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-eKZiaR dzZrgS section__button  " id="sectionButton"><span class="sc-htoDjs diutvq icon__dots dots__detector icon-colored _3n-7Ho7DlfjMlZbrRr9Q4a icon-themeable" title="" font-size="22"></span>Article Sections</button><div class="sc-bEjcJn jLUVhb static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-cbkKFq prcY sc-bGbJRg dVCLgr left_section_menu"><p>On this page</p><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abstract" aria-label="">Abstract</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#introduction" aria-label="">Introduction</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#materials-and-methods" aria-label="">Materials and Methods</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#results" aria-label="">Results</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#discussion" aria-label="">Discussion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#acknowledgments" aria-label="">Acknowledgments</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#references" aria-label="">References</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="sc-kDhYZr iySbrx desktop_tabs"><div class="sc-sPYgB bCmGAV"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO" href="/journals/ecam/2012/732578/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/ecam/2016/6728642/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row1"><div class="sc-sPYgB bCmGAV row1_edge_left"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO row1_link" href="/journals/ecam/2012/732578/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row1_link" href="/journals/ecam/2016/6728642/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV row1_edge_right"></div></div><div class="sc-bSbAYC fClRDD"><span class="sc-cFlXAS iomKnj">!</span><span class="sc-guztPN fexZtq alert__message">A <b>Corrigendum</b> for this article has been published.
  To view the article details, please click the Corrigendum tab above.</span></div><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 eGVCps"><div class="sc-chbbiW mBGSe article_header_class"><p class="sc-kZmsYB bkiEfx article_type">Research Article | <!-- -->Open Access</p><div class="sc-RcBXQ ztvYg article_citation">Volume<!-- --> <!-- -->2012<!-- --> <span class="sc-fZwumE cUsFHx">|</span>Article ID<!-- --> <!-- -->732578<!-- --> <span class="sc-fZwumE cUsFHx">| </span><a class="sc-htpNat bUhGXt link sc-fQejPQ duuwge" href="https://doi.org/10.1155/2012/732578" aria-label="Doi-link">https://doi.org/10.1155/2012/732578</a></div><div class="sc-LKuAh lcOiDF article_full_citation"><div class="sc-hzNEM gsmOCv isHide"><p>Chih-Yu Peng, Hui-Wen Yang, Yin-Hung Chu, Yu-Chao Chang, Ming-Ju Hsieh, Ming-Yung Chou, Kun-Tu Yeh, Yueh-Min Lin, Shun-Fa Yang, Chiao-Wen Lin<!-- -->,<!-- --> <!-- -->&quot;<span class="adjust-article-svg-size">Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway</span>&quot;,<!-- --> <i>Evidence-Based Complementary and Alternative Medicine</i>,<!-- --> <!-- -->vol. <!-- -->2012<!-- -->,<!-- --> <!-- -->Article ID <!-- -->732578<!-- -->,<!-- --> <!-- -->10<!-- --> <!-- --> <!-- --> <!-- -->pages<!-- -->,<!-- --> <!-- -->2012<!-- -->.<!-- --> <!-- -->https://doi.org/10.1155/2012/732578</p></div><button class="sc-hSdWYo etauus sc-iBEsjs kPshFw" color="">Show citation</button></div><h1 class="sc-iRbamj jZOxOO sc-iSDuPN kRoxOt article_title adjust-article-svg-size heading-title">Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway</h1></div><div class="sc-jrIrqw eHMFfo article_authors"><hr class="sc-cEvuZC XkrFe hr__author"/><span class="">Chih-Yu Peng<!-- -->,<sup>1<!-- -->,<!-- -->2</sup> </span><span class="">Hui-Wen Yang<!-- -->,<sup>1<!-- -->,<!-- -->2</sup> </span><span class="">Yin-Hung Chu<!-- -->,<sup>3</sup> </span><span class="">Yu-Chao Chang<!-- -->,<sup>1<!-- -->,<!-- -->2</sup> </span><span class="">Ming-Ju Hsieh<!-- -->,<sup>4</sup> </span><span class="">Ming-Yung Chou<!-- -->,<sup>1<!-- -->,<!-- -->2</sup> </span><span class="">Kun-Tu Yeh<!-- -->,<sup>5</sup> </span><span class="">Yueh-Min Lin<!-- -->,<sup>5</sup> </span><span class=""><b>Shun-Fa Yang</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a>,<sup>3<!-- -->,<!-- -->6</sup> <!-- --> and </span><span class=""><b>Chiao-Wen Lin</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a><sup>2<!-- -->,<!-- -->7</sup></span><div class="sc-fHxwqH dMuGGA isHide"><p><sup>1</sup><span>School of Dentistry, Chung Shan Medical University, Taichung 40201, Taiwan</span></p><p><sup>2</sup><span>Department of Dentistry, Chung Shan Medical University Hospital, Taichung 40201, Taiwan</span></p><p><sup>3</sup><span>Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan</span></p><p><sup>4</sup><span>School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan</span></p><p><sup>5</sup><span>Department of Pathology, Changhua Christian Hospital, Changhua 50006, Taiwan</span></p><p><sup>6</sup><span>Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan</span></p><p><sup>7</sup><span>Institute of Oral Sciences, Chung Shan Medical University, Taichung 40201, Taiwan</span></p></div><button class="sc-hSdWYo etauus sc-iQtOjA kfDwZY" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>Shrikant Anant</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">30 Sep 2012</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Revised</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">10 Nov 2012</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">19 Nov 2012</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">18 Dec 2012</span></div></div></div><article class="sc-jtRlXQ exFqMv article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0<i></i>M to 40<i></i>M). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>Oral cancer is associated with a high degree of local invasiveness and a high rate of metastasis to regional cervical lymph nodes. Oral squamous cell carcinoma (OSCC) is the most common head and neck cancer and is characterized by poor prognosis and low survival rate [<a href="#B1">1</a>]. Metastasis is the major cause of cancer death and involves multiple processes including the remodeling and degradation of the extracellular matrix (ECM) [<a href="#B2">2</a>]. Various proteinases, such as the matrix metalloproteinases (MMPs), cathepsins, and plasminogen activator (PA), are involved in the interactions between cancer cells and the ECM [<a href="#B3">3</a>, <a href="#B4">4</a>]. The MMPs function in the degradation of structural proteins in the ECM and regulate several cellular functions including growth, invasion, metastasis, and angiogenesis [<a href="#B5">5</a>]. Among the various MMPs thought to be involved in human disease, investigators have intensively investigated the gelatinases (MMP-2 and MMP-9). Matrix metalloproteinase-2 and MMP-9 are the principal enzymes involved in the degradation of the major structural component of the basement membrane, type IV collagen [<a href="#B6">6</a>, <a href="#B7">7</a>]. Several studies have shown that the gelatinases are overexpressed in several types of human cancer, such as breast [<a href="#B8">8</a>], pancreas [<a href="#B9">9</a>], prostate [<a href="#B10">10</a>], lung [<a href="#B11">11</a>], and oral [<a href="#B12">12</a>] cancers. Previous studies have also identified significantly increased urine and plasma MMP-2 concentrations in cancer patients [<a href="#B13">13</a>, <a href="#B14">14</a>], with MMP-2 and MMP-9 being considered as predictors of risk or recurrence of metastasis or as cancer prognostic markers [<a href="#B15">15</a>].</p><p>Caffeic acid phenethyl ester (CAPE) is one of the active components of honeybee propolis extracts [<a href="#B16">16</a>]. Previous research has shown that CAPE exerts antioxidative, anti-inflammatory, and anticancer activities [<a href="#B17">17</a>]. In addition, CAPE suppresses eicosanoid synthesis and inhibits the release of arachidonic acid from cell membranes [<a href="#B17">17</a>, <a href="#B18">18</a>]. Its anti-inflammatory activity is derived from the downregulation of COX-2 expression [<a href="#B19">19</a>, <a href="#B20">20</a>]. Chuu et al. identified that CAPE suppressed human prostate cancer cell proliferation through the inhibition of Akt [<a href="#B21">21</a>]. Other studies have shown that CAPE induced apoptosis through the activation of Fas and Bax and the inhibition of NF-<svg height="7.9499998" id="M1" style="vertical-align:-0.1638pt;width:8.7375002px;" version="1.1" viewbox="0 0 8.7375002 7.9499998" width="8.7375002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,7.675)"><path d="M484 406q0 -21 -22 -38q-10 -7 -18 -1q-15 11 -30 11q-30 0 -77.5 -37t-74.5 -67l79 -168q11 -23 19.5 -34.5t13 -14t10.5 -2.5q9 0 30 17.5t40 42.5l17 -23q-31 -45 -57.5 -69.5t-40.5 -29.5t-31 -5q-18 0 -32 13.5t-35 55.5q-34 71 -69 160q-36 -32 -59 -56&#10;q-12 -27 -36 -158q-44 -7 -77 -15l-5 7l82 349q6 25 -2 25q-16 0 -72 -41l-14 22q44 41 89 69.5t66 28.5q19 0 19 -32q0 -16 -6 -43l-35 -160l146 143q94 92 136 92q20 0 33 -12t13 -30z" id="x1D705"></path></g>
</svg>B [<a href="#B22">22</a>, <a href="#B23">23</a>]. However, its effects on OSCC invasion and metastasis and their underlying mechanisms have yet to be fully elucidated.</p><p>This study investigated the association between CAPE treatment and invasion of SCC-9 oral cancer cells. Our results showed that CAPE suppressed the migration and invasion of oral cancer cells, probably through the inhibition of FAK phosphorylation and its downstream p38 and JNK signaling pathways. Results also indicated that the anti-invasive activity of CAPE is partly mediated by the regulation of MMP-2 expression and activity, which reduces the ability of oral cancer cells to degrade components of the extracellular matrix.</p><h4 id="materials-and-methods">2. Materials and Methods</h4><h5 id="sec2.1">2.1. Cell Culture and CAPE Treatment</h5><p>SCC-9, a human tongue squamous cell carcinoma cell line obtained from ATCC (Manassas, VA, USA), was cultured in Dulbeccos Modified Eagles Medium supplemented with a nutrient mixture, which comprised F-12 Hams medium (Life Technologies, Grand Island, NY, USA), 10% fetal bovine serum (Hyclone Laboratories, Logan, UT, USA), 2mM glutamine, 100U/mL penicillin, and 100<i></i>g/mL streptomycin. All cell cultures were maintained at 37C in a humidified atmosphere of 5%CO<sub>2</sub>. For CAPE treatment, appropriate amounts of stock solution of CAPE were added into culture medium to achieve the indicated concentrations and then incubated with cells for indicated time periods, whereas dimethyl sulfoxide solution without CAPE was used as blank reagent.</p><h5 id="sec2.2">2.2. Determination of Cell Viability (MTT Assay)</h5><p>For cell viability experiment, a microculture tetrazolium (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay was performed to determine the cytotoxicity of CAPE [<a href="#B3">3</a>]. SCC-9 cells were seeded in 24-well plates at a density of <svg height="16.012501" id="M2" style="vertical-align:-0.1638pt;width:48.474998px;" version="1.1" viewbox="0 0 48.474998 16.012501" width="48.474998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,15.738)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g><g transform="matrix(.017,-0,0,-.017,11.996,15.738)"><path d="M528 54l-36 -38l-198 201l-198 -201l-36 38l197 200l-197 201l36 38l198 -202l198 202l36 -38l-197 -201z" id="xD7"></path></g><g transform="matrix(.017,-0,0,-.017,25.748,15.738)"><path d="M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z" id="x31"></path></g><g transform="matrix(.017,-0,0,-.017,33.907,15.738)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g>
<g transform="matrix(.012,-0,0,-.012,42.075,7.587)"><path d="M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z" id="x34"></path></g>
</svg> cells/well and treated with CAPE at a concentration between 0 and 40<i></i>M at 37C for 24 and 48h. After the exposure period, the media were removed, and cells were washed with phosphate-buffered saline (PBS) and then incubated with 20<i></i>L MTT (5mg/mL) (Sigma chemical Co., St. Louis, MO, USA) for 4h. The viable cell number per dish is directly proportional to the production of formazan, which can be measured spectrophotometrically at 563nm following solubilization with isopropanol.</p><h5 id="sec2.3">2.3. Annexin V/PI Double Staining</h5><p>An FITC Annexin V Apoptosis Detection Kit I was used to quantify cell numbers in different stages of cell death. Briefly, <svg height="15.9" id="M3" style="vertical-align:-0.1638pt;width:48.474998px;" version="1.1" viewbox="0 0 48.474998 15.9" width="48.474998" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,15.638)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,11.996,15.638)"><use xlink:href="#xD7"></use></g><g transform="matrix(.017,-0,0,-.017,25.748,15.638)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,33.907,15.638)"><use xlink:href="#x30"></use></g>
<g transform="matrix(.012,-0,0,-.012,42.075,7.475)"><use xlink:href="#x35"></use></g>
</svg> cells were resuspended in 100<i></i>L 1x binding buffer (0.01M Hepes/NaOH (pH 7.4), 0.14M NaCl, and 2.5mM CaCl<sub>2</sub>). With an addition of 5<i></i>L of FITC Annexin V and 5<i></i>L PI, the cell suspension was incubated for 15 minutes at room temperature in the dark. Afterwards, 400<i></i>L of 1x binding buffer was added to each tube followed by flow cytometry analysis within 1 hour.</p><h5 id="sec2.4">2.4. In Vitro Wound Closure</h5><p>SCC-9 cells (1  10<sup>5</sup> cells/well) were plated in 6-well plates for 24h, wounded by scratching with a pipette tip, then incubated with DMEM medium containing 0.5% FBS, and treated with or without CAPE (0, 5, 10, 20, and 40<i></i>M) for 0, 24, 48, and 72h. Cells were photographed using a phase-contrast microscope (<svg height="11.125" id="M4" style="vertical-align:-0.1638pt;width:34.575001px;" version="1.1" viewbox="0 0 34.575001 11.125" width="34.575001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#xD7"></use></g><g transform="matrix(.017,-0,0,-.017,10.041,10.862)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,18.2,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,26.36,10.862)"><use xlink:href="#x30"></use></g>
</svg>).</p><h5 id="sec2.5">2.5. Cell Migration and Invasion Assays</h5><p>Cell migration and invasion were assayed according to the methods described by Yang et al. [<a href="#B4">4</a>]. After a treatment with CAPE (0, 5, 10, 20, and 40<i></i>M) for 24h, surviving cells were harvested and seeded to Boyden chamber (Neuro Probe, Cabin John, MD, USA) at 10<sup>4</sup>cells/well in serum-free medium and then incubated for 24 hours at 37C. For invasion assay, 10<i></i>L Matrigel (25mg/50mL; BD Biosciences, MA, USA) was applied to 8<i></i>m pore-size polycarbonate membrane filters, and the bottom chamber contained standard medium. Filters were then air-dried for 5h in a laminar flow hood. The invaded cells were fixed with 100% methanol and stained with 5% Giemsa. Cell numbers were counted under a light microscope. The migration assay was carried out as described in the invasion assay with no coating of Matrigel [<a href="#B3">3</a>].</p><h5 id="sec2.6">2.6. Determination of MMP-2 by Gelatin Zymography</h5><p>The activities of MMP-2 in conditional medium were measured by gelatin zymography protease assays as previously described [<a href="#B3">3</a>]. Briefly, collected media of an appropriate volume (adjusted by vital cell number) were prepared with SDS sample buffer without boiling or reduction and subjected to 0.1% gelatin and 8% SDS-PAGE electrophoresis. After electrophoresis, gels were washed with 2.5% Triton X-100 and then incubated in reaction buffer (40mM TrisHCl, pH 8.0, 10mM CaCl<sub>2</sub>, and 0.01% NaN<sub>3</sub>) for 12h at 37C. Then the gel was stained with Coomassie Brilliant Blue R-250. </p><h5 id="sec2.7">2.7. Preparation of Total Cell Lysates</h5><p>For total cell lysates preparation, cells were rinsed with PBS twice, scraped with 0.2mL of cold RIPA buffer containing protease inhibitors cocktail, and then vortexed at 4C for 10min. Cell lysates were subjected to a centrifugation of 10,000rpm for 10min at 4C, and the insoluble pellet was discarded. The protein concentration of total cell lysates and nuclear fraction was determined by Bradford assay [<a href="#B3">3</a>]. </p><h5 id="sec2.8">2.8. Western Blot Analysis</h5><p>The cell lysates were separated in a 10% polyacrylamide gel and transferred onto a nitrocellulose membrane. The blot was subsequently incubated with 5% nonfat milk in Tris-buffered saline (20mM Tris, 137mM NaCl, pH 7.6) for 1h to block nonspecific binding and then incubated overnight with polyclonal antibodies against MMP-2, TIMP-2, caspase 3, 8, and 9, three MAPKs (ERK 1/2, JNK 1/2, and p38), Akt, or FAK with the specific antibodies for unphosphorylated or phosphorylated forms of the corresponding ERK 1/2, JNK 1/2, p38, Akt, and FAK. Blots were then incubated with a horseradish peroxidase goat anti-rabbit or anti-mouse IgG for 1h. Afterwards, signal was detected by using enhanced chemiluminescence (ECL) commercial kit (Amersham Biosciences), and relative photographic density was quantitated by scanning the photographic negatives on a gel documentation and analysis system (AlphaImager 2000, Alpha Innotech Corporation, San Leandro, CA, USA).</p><h5 id="sec2.9">2.9. Statistical Analysis</h5><p>Statistical significances of difference throughout this study were calculated by Students <svg height="10.3875" id="M5" style="vertical-align:-0.1638pt;width:5.9250002px;" version="1.1" viewbox="0 0 5.9250002 10.3875" width="5.9250002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.125)"><path d="M324 430l-26 -36l-112 -4l-55 -265q-13 -66 7 -66q13 0 44.5 20t50.5 40l17 -24q-38 -40 -85.5 -73.5t-87.5 -33.5q-50 0 -21 138l55 262h-80l-2 8l25 34h66l25 99l78 63l10 -9l-37 -153h128z" id="x1D461"></path></g>
</svg>-test (Sigma-Stat 2.0, Jandel Scientific, San Rafael, CA, USA). A difference at <svg height="11.375" id="M6" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg> was considered to be statistically significant, and the experiments were repeated three times. </p><h4 id="results">3. Results</h4><h5 id="sec3.1">3.1. Effects of CAPE on SCC-9 Cell Viability</h5><p>  Figure <a href="fig1/#a" target="_blank">1(a)</a> displays the cytotoxic effects of various concentrations of CAPE (0<i></i>M40<i></i>M) on SCC-9 cells for 24hr and 48hr. Results from MTT assay showed that all concentrations, including the highest tested CAPE concentration (40<i></i>M), had nonsignificant effects on SCC-9 cell viability compared to controls (<svg height="11.375" id="M7" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 230l-437 -233v58l378 199v2l-378 200v58l437 -233v-51z" id="x3E"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>). Furthermore, CAPE also did not alter the cell viability of normal gingival fibroblast at various concentrations (040<i></i>M) for 24h (Figure <a href="fig1/#b" target="_blank">1(b)</a>). Thus, all subsequent experiments, therefore, used this CAPE concentration range.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig1"><div class="floats-partial-content fig-content-fig1"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.001a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.001b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig1"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.001a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.001b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig1"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 1</span><a aria-label="full view" class="caption-partial-url" href="fig1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of CAPE on cell viability. (a) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40<i></i>M) for 24h and 48h before being subjected to an MTT assay for cell viability. (b) Normal gingival fibroblast cells were treated with CAPE (0, 5, 10, 20, and 40<i></i>M) for 24h before being subjected to an MTT assay for cell viability. The values represented the means  SD of at least three independent experiments. </table></div></div></div><p>We further investigated the effect of CAPE on Annexin V flipping and caspase cleavage. Our results showed that treatment of SCC-9 cells with CAPE (040<i></i>M) for 24h did not increase the incidence of apoptosis as evidenced without significant changes in the Annexin V/PI double staining (Figure <a href="fig2/#a" target="_blank">2(a)</a>) and caspase 3, 8, and 9 expression levels (Figure <a href="fig2/#b" target="_blank">2(b)</a>) between control and CAPE-treated SCC-9 cells (<svg height="11.375" id="M8" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3E"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>). </p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig2"><div class="floats-partial-content fig-content-fig2"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig2"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.002a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.002b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig2"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 2</span><a aria-label="full view" class="caption-partial-url" href="fig2/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of CAPE on the Annexin V flipping and caspase cleavage in SCC-9 cells. SCC-9 cells were treated with CAPE (040<i></i>M) for 24h and then subjected to Annexin V and PI double-stained flow cytometry (a) or Western blotting to analyze the protein levels of caspase 3, 8, and 9 (b).</table></div></div></div><h5 id="sec3.2">3.2. Inhibition of SCC-9 Cell Motility, Migration, and Invasion by CAPE</h5><p>  In the wound-healing assay, CAPE significantly reduced the cell motility of SCC-9 cells both dose and time dependently (<svg height="11.375" id="M9" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>) (Figures <a href="fig3/#a" target="_blank">3(a)</a> and <a href="fig3/#b" target="_blank">3(b)</a>). At 40<i></i>M, CAPE decreased the migrated cell number by 38%, 56%, and 82% at 24h, 48h, and 72h, respectively. Using a cell migration and invasion assay with a Boyden chamber, we showed that CAPE reduced SCC-9 cell migration and invasion significantly and in a concentration-dependent manner (<svg height="11.375" id="M10" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>) (Figures <a href="fig4/#a" target="_blank">4(a)</a> and <a href="fig4/#b" target="_blank">4(b)</a>). In the invasion assay, the inhibition percentage was 1664% (Figure <a href="fig4/#b" target="_blank">4(b)</a>) after incubation of cells with different concentrations (040 <i></i>M) of CAPE for 24h. Our results indicated increased inhibition of cell migration with increasing CAPE concentration.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig3"><div class="floats-partial-content fig-content-fig3"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig3"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.003a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.003b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig3"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 3</span><a aria-label="full view" class="caption-partial-url" href="fig3/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of CAPE on in vitro wound closure in oral cancer cells. (a) SCC-9 cells were wounded and then treated with vehicle (DMSO) or CAPE (0, 5, 10, 20, and 40<i></i>M) for 0h, 24h, 48h, and 72h in 0.5% FBS-containing medium. At 0, 24h, 48 and 72h, phase-contrast pictures of the wounds at three different locations were taken. (b) Cells migrating into the wound area were counted using the dashed line as time zero. A quantitative assessment of the mean number of cells in the denuded zone is the mean  SD (<svg height="11.125" id="M11" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 36.237499 11.125" width="36.237499" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><path d="M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2&#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z" id="x1D45B"></path></g><g transform="matrix(.017,-0,0,-.017,13.305,10.862)"><path d="M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z" id="x3D"></path></g><g transform="matrix(.017,-0,0,-.017,28.008,10.862)"><path d="M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5&#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z" id="x33"></path></g>
</svg>).</table></div></div></div><div class="floats-partial-section partial-carousel-wrapper" data-section="fig4"><div class="floats-partial-content fig-content-fig4"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig4"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.004a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.004b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig4"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 4</span><a aria-label="full view" class="caption-partial-url" href="fig4/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of CAPE on cell migration and invasion in SCC-9 cells. (a) The cell migration and (b) cell invasion were measured using a Boyden chamber for 16h and 24h with polycarbonate filters, respectively. The migration and invasion abilities of SCC-9 cells were quantified by counting the number of cells that invaded to the underside of the porous polycarbonate as described in Section <a href="#sec2">2</a>. The values represented the means  SD of at least three independent experiments. *<svg height="11.375" id="M12" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg> as compared with the vehicle group. </table></div></div></div><h5 id="sec3.3">3.3. Effects of CAPE on MMP-2 and TIMP-2 Protein Expressions and MMP-2 Enzymatic Activity</h5><p>   To confirm that MMP-2 plays a vital role in the suppression of cell migration, we compared MMP-2 protein expression in CAPE-treated and control SCC-9 cells. As shown in Figures <a href="fig5/" target="_blank">5</a>(a) and <a href="fig5/" target="_blank">5</a>(b), treatment of SCC-9 cells with CAPE downregulated MMP-2 enzymatic activity in a concentration-dependent manner (<svg height="11.375" id="M13" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>). At 40 <i></i>M, CAPE decreased the MMP-2 enzymatic activity by 57% at 24h. CAPE also significantly reduced MMP-2 protein expressions and increased TIMP-2 expression in western blotting (Figures <a href="fig5/" target="_blank">5</a>(c) and <a href="fig5/" target="_blank">5</a>(d)). CAPE (40<i></i>M) increased TIMP-2 expression with about 1.58 folds at 24h.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig5"><div class="floats-partial-content fig-content-fig5"><div class="partial-carousel--single-image"><img alt="" name="732578.fig.005" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.005.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 5</span><a aria-label="full view" class="caption-partial-url" href="fig5/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of CAPE on the activity and protein level of MMP-2 and the protein level of the endogenous inhibitor TIMP-2. (a-b) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40 <i></i>M) for 24h and then subjected to gelatin zymography to analyze the activity of MMP-2. (c-d) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40<i></i>M) for 24h and then subjected to western blotting to analyze the protein levels of MMP-2 and TIMP-2. Quantitative results of MMP-2 and TIMP-2 protein levels which were adjusted with <svg height="16.6625" id="M14" style="vertical-align:-3.56265pt" version="1.1" viewbox="0 0 10 16.6625" width="10" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,12.162)"><path d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5&#10;t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" id="x1D6FD"></path></g>
</svg>-actin protein level. The values represented the means  SD of at least three independent experiments. *<svg height="11.375" id="M15" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg> as compared with the vehicle group. </table></div></div></div><h5 id="sec3.4">3.4. Effects of CAPE on Focal Adhesion Kinase (FAK) Activation</h5><p>   Our investigation of the molecular regulation of cell migration indicated the involvement of FAK in CAPE activity. Having shown that CAPE inhibits SCC-9 cell migration and invasion, we further aimed to evaluate any changes in FAK activation in these cells using antibodies directed against the FAK phosphorylation site Tyr397. As shown in Figure <a href="fig6/" target="_blank">6</a>, CAPE reduced FAK phosphorylation in SCC-9 cells. The inhibition percentage was 2042% (Figure <a href="fig6/#b" target="_blank">6(b)</a>) after incubation of cells with different concentrations of CAPE for 24h. These results suggested that CAPE inhibits SCC-9 cell migration, at least in part, through the regulation of FAK phosphorylation.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig6"><div class="floats-partial-content fig-content-fig6"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.006a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.006b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig6"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.006a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.006b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig6"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 6</span><a aria-label="full view" class="caption-partial-url" href="fig6/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of CAPE on the phosphorylation level of FAK. (a) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40 <i></i>M) for 24h and then subjected to western blotting to analyze the levels of FAK. (b) Quantitative results of phosphorylation level of FAK which were adjusted with total FAK protein level. The values represented the means  SD of at least three independent experiments. *<svg height="11.375" id="M16" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg> as compared with the vehicle group. </table></div></div></div><h5 id="sec3.5">3.5. Effects of CAPE on MAPK and PI3K/Akt Pathways</h5><p>   We investigated the effects of CAPE on MAPK and PI3K/Akt pathways using western blot analysis. Results indicated the constitutive phosphorylation of pERK (Figure <a href="fig7/#a" target="_blank">7(a)</a>) and pAKT (Figure <a href="fig7/#d" target="_blank">7(d)</a>) in untreated SCC-9 cells and the downregulation of p38 (Figure <a href="fig7/#b" target="_blank">7(b)</a>) and pJNK (Figure <a href="fig7/#c" target="_blank">7(c)</a>) phosphorylation in CAPE-treated cells in a dose-dependent manner (<svg height="11.375" id="M17" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>). At 40<i></i>M, CAPE decreased phosphorylation levels of p38 and JNK by 51% and 40%, respectively.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig7"><div class="floats-partial-content fig-content-fig7"><div class="partial-carousel--single-image"><img alt="(a)" name="732578.fig.007a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="732578.fig.007b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="732578.fig.007c" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="732578.fig.007d" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig7"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="732578.fig.007a" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="732578.fig.007b" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="732578.fig.007c" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="732578.fig.007d" src="https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig7"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 7</span><a aria-label="full view" class="caption-partial-url" href="fig7/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of CAPE on the MAPKs pathway and Akt signalings. SCC-9 cells were cultured in various concentrations of CAPE (0, 5, 10, 20, and 40<i></i>M) for 24 hours, and then the cell lysates were subjected to SDS-PAGE followed by western blots with (a) anti-ERK1/2, (b) anti-p38, (c) anti-JNK, and (d) anti-Akt (total and phosphorylated) antibodies as described in Section <a href="#sec2">2</a>. Determined activities of these proteins were subsequently quantified by densitometric analyses with that of control being 100% as shown just after the gel data. The values represented the means  SD of at least 3 independent experiments. *<svg height="11.375" id="M18" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg> as compared with the vehicle group.</table></div></div></div><h4 id="discussion">4. Discussion</h4><p>The management of patients with malignant tumors has improved greatly over the past few decades. Patients with OSCC now have an overall 5-year survival rate of approximately 25% [<a href="#B24">24</a>]. However, patients with advanced disease often experience cancer spread to local and distant sites, which is poorly controlled by surgery. Our results suggested that CAPE could have potential use as an inhibitor of oral cancer metastasis and could, therefore, facilitate the development of effective anticancer therapies. We identified that CAPE (1) inhibits migration and invasion of SCC-9 oral cancer cells at noncytotoxic concentrations, (2) downregulates MMP-2 protein expression and inhibits its enzymatic activity, (3) increases TIMP-2 expression, (4) inhibits FAK phosphorylation, (5) and inhibits p38 MAPK and JNK activation.</p><p>Invasion and migration are considered the most important characteristics of malignant tumors. Solid tumor metastasis is the major cause of death in human cancer patients and involves multiple complicated processes. The degradation of the ECM is considered essential for tumor progression [<a href="#B25">25</a>]. Among various proteases, which cause ECM degradation, matrix metalloproteinase-2 is the most significant in oral cancer [<a href="#B26">26</a>]. Previous studies investigated the clinical significance of MMP-2 in different races with oral cancer. Immunohistochemical results indicated that MMP-2 expression significantly elevated in malignant tissues as compared with adjacent normal tissues. MMP-2 overexpression positively correlated with lymph node metastasis [<a href="#B27">27</a>, <a href="#B28">28</a>]. The activation ratio of MMP-2 was higher in the malignant tissues of patients with lymph node metastasis as compared with those without lymph node metastasis [<a href="#B29">29</a>]. OSCC invasion and metastasis represent major obstacles to treatment. Thus, inhibition of metastasis of OSCC by CAPE could provide important preventive and therapeutic benefitsagainst oral cancer.</p><p>The result of this studys showed that CAPE significantly inhibited the migratory/invasive ability of SCC-9 cancer cells, downregulated MMP-2 protein expression, and inhibited MMP-2 enzymatic activity. However, our data also indicated that the secreted concentrations of MMP-9 from SCC-9 cells were quite low (data not shown). The function of the MMP in vivo is dependent on the local balance between them and their natural inhibitors [<a href="#B30">30</a>]. The TIMPs are physiological inhibitors that bind MMP in a 1:1 stoichiometry. Several studies have suggested that measuring the protease/protease inhibitor ratio in some tumors can provide an exact reflection of ECM remolding [<a href="#B31">31</a>]. However, the relationship between metastasis and TIMP-2 remains controversial. In previous studies, TIMP-2 overexpression protected cancer cells from apoptosis and reduced cell invasion in various tumor cell lines [<a href="#B32">32</a>, <a href="#B33">33</a>]. In other clinical analyses, TIMP-2 expression was positively associated with tumor recurrence [<a href="#B34">34</a>]. Our data suggested a role for TIMP-2 in the prevention of tumor cell invasion because its expression is upregulated in CAPE-treated SCC-9 cells. </p><p>Previous studies have well established the role of the Mitogen-activated protein kinase (MAPK) pathway in the regulation of MMP expression and metastasis of tumor cells [<a href="#B35">35</a><a href="#B37">37</a>]. Inhibition of p38 by SB203580 reduced the rate of migration of several cancer cells significantly [<a href="#B38">38</a>]. In the study by Huang et al., the dominant-negative mutant of JNK inhibited the migration of human corneal epithelial cells [<a href="#B39">39</a>]. In other studies, both p38 and JNK modulated MMP-2 production in cancer cells [<a href="#B40">40</a><a href="#B42">42</a>]. Our data showed that CAPE treatment inhibited p38 and JNK phosphorylation and downregulated MMP-2 expression, indicating a possible mechanism for the inhibition of MMP-2 synthesis by CAPE. The phosphoinositide-3 kinase (PI3K)/Akt signal transduction pathway is involved in MMP production and cell proliferation, survival, and migration [<a href="#B43">43</a>]; however, our study results indicated that CAPE has nonsignificant effects on the PI3K/AKT signaling pathway.</p><p>In conclusion, the result of our study suggested that CAPE partly exerts its antimetastatic effects on oral cancer cells by regulating MMP-2 expression through the inhibition of FAK and MAPK activation. Overall, these data suggest that CAPE has a potential use as a chemoagent for the prevention of oral cancer cell metastasis.</p><h4 id="acknowledgments">Acknowledgments</h4><p>This study was supported by a research Grant from the National Science Council, Taiwan (no. NSC100-2632-B-040-001-MY3) and a research Grant from Chung Shan Medical University (no. G101N0001), Taiwan.</p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">R. H. Spiro, A. E. Alfonso, H. W. Farr, and E. W. Strong, Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging, <i>American Journal of Surgery</i>, vol. 128, no. 4, pp. 562567, 1974. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Cervical%20node%20metastasis%20from%20epidermoid%20carcinoma%20of%20the%20oral%20cavity%20and%20oropharynx.%20A%20critical%20assessment%20of%20current%20staging&author=R. H. Spiro&author=A. E. Alfonso&author=H. W. Farr&author=&author=E. W. Strong&publication_year=1974" target="_blank">Google Scholar</a></span><li id="B2">W. G. Stetler-Stevenson, L. A. Liotta, and D. E. Kleiner, Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis, <i>FASEB Journal</i>, vol. 7, no. 15, pp. 14341441, 1993. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Extracellular%20matrix%206:%20role%20of%20matrix%20metalloproteinases%20in%20tumor%20invasion%20and%20metastasis&author=W. G. Stetler-Stevenson&author=L. A. Liotta&author=&author=D. E. Kleiner&publication_year=1993" target="_blank">Google Scholar</a></span><li id="B3">M. H. Chien, T. H. Ying, Y. S. Hsieh et al., Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity, <i>Food and Chemical Toxicology</i>, vol. 50, pp. 558566, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dioscorea%20nipponica%20Makino%20inhibits%20migration%20and%20invasion%20of%20human%20oral%20cancer%20HSC-3%20cells%20by%20transcriptional%20inhibition%20of%20matrix%20metalloproteinase-2%20through%20modulation%20of%20CREB%20and%20AP-1%20activity&author=M. H. Chien&author=T. H. Ying&author=Y. S. Hsieh et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B4">S. F. Yang, M. K. Chen, Y. S. Hsieh et al., Antimetastatic effects of <i>Terminalia catappa</i> L. on oral cancer via a down-regulation of metastasis-associated proteases, <i>Food and Chemical Toxicology</i>, vol. 48, no. 4, pp. 10521058, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.fct.2010.01.019">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antimetastatic%20effects%20of%20Terminalia%20catappa%20L.%20on%20oral%20cancer%20via%20a%20down-regulation%20of%20metastasis-associated%20proteases&author=S. F. Yang&author=M. K. Chen&author=Y. S. Hsieh et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B5">M. Egeblad and Z. Werb, New functions for the matrix metalloproteinases in cancer progression, <i>Nature Reviews Cancer</i>, vol. 2, no. 3, pp. 161174, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=New%20functions%20for%20the%20matrix%20metalloproteinases%20in%20cancer%20progression&author=M. Egeblad &author=Z. Werb&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B6">A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian, Matrix metalloproteinases: biologic activity and clinical implications, <i>Journal of Clinical Oncology</i>, vol. 18, no. 5, pp. 11351149, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases:%20biologic%20activity%20and%20clinical%20implications&author=A. R. Nelson&author=B. Fingleton&author=M. L. Rothenberg&author=&author=L. M. Matrisian&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B7">M. Bj&#xf6;rklund and E. Koivunen, Gelatinase-mediated migration and invasion of cancer cells, <i>Biochimica et Biophysica Acta</i>, vol. 1755, no. 1, pp. 3769, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bbcan.2005.03.001">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Gelatinase-mediated%20migration%20and%20invasion%20of%20cancer%20cells&author=M. Bjrklund &author=E. Koivunen&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B8">S. M. Ranuncolo, E. Armanasco, C. Cresta, E. B. De Kier Joffe, and L. Puricelli, Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients, <i>International Journal of Cancer</i>, vol. 106, no. 5, pp. 745751, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ijc.11288">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Plasma%20MMP-9%20(92%20kDa-MMP)%20activity%20is%20useful%20in%20the%20follow-up%20and%20in%20the%20assessment%20of%20prognosis%20in%20breast%20cancer%20patients&author=S. M. Ranuncolo&author=E. Armanasco&author=C. Cresta&author=E. B. De Kier Joffe&author=&author=L. Puricelli&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B9">M. Yokoyama, K. Ochi, M. Ichimura et al., Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer, <i>Pancreas</i>, vol. 24, no. 4, pp. 344347, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1097/00006676-200205000-00004">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase-2%20in%20pancreatic%20juice%20for%20diagnosis%20of%20pancreatic%20cancer&author=M. Yokoyama&author=K. Ochi&author=M. Ichimura et al.&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B10">C. G. Sauer, A. Kappeler, M. Sp&#xe4;th et al., Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients, <i>Virchows Archiv</i>, vol. 444, no. 6, pp. 518526, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Expression%20and%20activity%20of%20matrix%20metalloproteinases-2%20and%20-9%20in%20serum,%20core%20needle%20biopsies%20and%20tissue%20specimens%20of%20prostate%20cancer%20patients&author=C. G. Sauer&author=A. Kappeler&author=M. Spth et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B11">G. Bugdayci, T. Kaplan, S. Sezer et al., Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer, <i>Experimental Oncology</i>, vol. 28, no. 2, pp. 169171, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase-9%20in%20broncho-alveolar%20lavage%20fluid%20of%20patients%20with%20non-small%20cell%20lung%20cancer&author=G. Bugdayci&author=T. Kaplan&author=S. Sezer et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B12">S. D. Hong, S. P. Hong, J. I. Lee, and C. Y. Lim, Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential, <i>Oral Oncology</i>, vol. 36, no. 2, pp. 207213, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1368-8375(99)00088-3">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Expression%20of%20matrix%20metalloproteinase-2%20and%20-9%20in%20oral%20squamous%20cell%20carcinomas%20with%20regard%20to%20the%20metastatic%20potential&author=S. D. Hong&author=S. P. Hong&author=J. I. Lee&author=&author=C. Y. Lim&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B13">C. M. Coticchia, A. S. Curatolo, D. Zurakowski et al., Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels, <i>Gynecologic Oncology</i>, vol. 123, pp. 295300, 2011. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Urinary%20MMP-2%20and%20MMP-9%20predict%20the%20presence%20of%20ovarian%20cancer%20in%20women%20with%20normal%20CA125%20levels&author=C. M. Coticchia&author=A. S. Curatolo&author=D. Zurakowski et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B14">T. S. Wong, D. L. W. Kwong, J. S. T. Sham, W. I. Wei, Y. L. Kwong, and A. P. W. Yuen, Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma, <i>European Journal of Surgical Oncology</i>, vol. 30, no. 5, pp. 560564, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ejso.2004.02.007">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Clinicopathologic%20significance%20of%20plasma%20matrix%20metalloproteinase-2%20and%20-9%20levels%20in%20patients%20with%20undifferentiated%20nasopharyngeal%20carcinoma&author=T. S. Wong&author=D. L. W. Kwong&author=J. S. T. Sham&author=W. I. Wei&author=Y. L. Kwong&author=&author=A. P. W. Yuen&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B15">N. Song, H. Sung, J. Y. Choi et al., Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women, <i>Cancer Epidemiology, Biomarkers &#x26; Prevention</i>, vol. 21, pp. 13711380, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Preoperative%20serum%20levels%20of%20matrix%20metalloproteinase-2%20(MMP-2)%20and%20survival%20of%20breast%20cancer%20among%20Korean%20women&author=N. Song&author=H. Sung&author=J. Y. Choi et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B16">J. W. Dobrowolski, S. B. Vohora, K. Sharma, S. A. Shah, S. A. H. Naqvi, and P. C. Dandiya, Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products, <i>Journal of Ethnopharmacology</i>, vol. 35, no. 1, pp. 7782, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibacterial,%20antifungal,%20antiamoebic,%20antiinflammatory%20and%20antipyretic%20studies%20on%20propolis%20bee%20products&author=J. W. Dobrowolski&author=S. B. Vohora&author=K. Sharma&author=S. A. Shah&author=S. A. H. Naqvi&author=&author=P. C. Dandiya&publication_year=1991" target="_blank">Google Scholar</a></span><li id="B17">P. Michaluart, J. L. Masferrer, A. M. Carothers et al., Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation, <i>Cancer Research</i>, vol. 59, no. 10, pp. 23472352, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Inhibitory%20effects%20of%20caffeic%20acid%20phenethyl%20ester%20on%20the%20activity%20and%20expression%20of%20cyclooxygenase-2%20in%20human%20oral%20epithelial%20cells%20and%20in%20a%20rat%20model%20of%20inflammation&author=P. Michaluart&author=J. L. Masferrer&author=A. M. Carothers et al.&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B18">O. K. Mirzoeva, P. Yaqoob, K. A. Knox, and P. C. Calder, Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis, <i>FEBS Letters</i>, vol. 396, no. 2-3, pp. 266270, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0014-5793(96)01111-8">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20ICE-family%20cysteine%20proteases%20rescues%20murine%20lymphocytes%20from%20lipoxygenase%20inhibitor-induced%20apoptosis&author=O. K. Mirzoeva&author=P. Yaqoob&author=K. A. Knox&author=&author=P. C. Calder&publication_year=1996" target="_blank">Google Scholar</a></span><li id="B19">Y. Lee, D. H. Shin, J. H. Kim et al., Caffeic acid phenethyl ester-mediated Nrf2 activation and I<i>&#x3ba;</i>B kinase inhibition are involved in NF<i>&#x3ba;</i>B inhibitory effect: structural analysis for NF<i>&#x3ba;</i>B inhibition, <i>European Journal of Pharmacology</i>, vol. 643, no. 1, pp. 2128, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ejphar.2010.06.016">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester-mediated%20Nrf2%20activation%20and%20IB%20kinase%20inhibition%20are%20involved%20in%20NFB%20inhibitory%20effect:%20structural%20analysis%20for%20NFB%20inhibition&author=Y. Lee&author=D. H. Shin&author=J. H. Kim et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B20">W. K. Jung, D. Y. Lee, Y. H. Choi et al., Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma, <i>Life Sciences</i>, vol. 82, no. 13-14, pp. 797805, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.lfs.2008.01.014">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester%20attenuates%20allergic%20airway%20inflammation%20and%20hyperresponsiveness%20in%20murine%20model%20of%20ovalbumin-induced%20asthma&author=W. K. Jung&author=D. Y. Lee&author=Y. H. Choi et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B21">C. P. Chuu, H. P. Lin, M. F. Ciaccio et al., Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks, <i>Cancer Prevention Research</i>, vol. 5, pp. 788797, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester%20suppresses%20the%20proliferation%20of%20human%20prostate%20cancer%20cells%20through%20inhibition%20of%20p70S6K%20and%20Akt%20signaling%20networks&author=C. P. Chuu&author=H. P. Lin&author=M. F. Ciaccio et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B22">Y. T. Lee, M. J. Don, P. S. Hung et al., Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells, <i>Cancer Letters</i>, vol. 223, no. 1, pp. 1925, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.canlet.2004.09.048">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Cytotoxicity%20of%20phenolic%20acid%20phenethyl%20esters%20on%20oral%20cancer%20cells&author=Y. T. Lee&author=M. J. Don&author=P. S. Hung et al.&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B23">M. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki, caffeic acid phenethyl ester induces apoptosis by inhibition of
NFkappaB and activation of Fas in human breast cancer MCF-7 cells, <i>Journal of Biological Chemistry</i>, vol. 279, no. 7, pp. 60176026, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M306040200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=caffeic%20acid%20phenethyl%20ester%20induces%20apoptosis%20by%20inhibition%20of
NFkappaB%20and%20activation%20of%20Fas%20in%20human%20breast%20cancer%20MCF-7%20cells&author=M. Watabe&author=K. Hishikawa&author=A. Takayanagi&author=N. Shimizu&author=&author=T. Nakaki&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B24">T. Ramqvist and T. Dalianis, Oropharyngeal cancer epidemic and human papillomavirus, <i>Emerging Infectious Diseases</i>, vol. 16, no. 11, pp. 16711677, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1611.100452">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Oropharyngeal%20cancer%20epidemic%20and%20human%20papillomavirus&author=T. Ramqvist &author=T. Dalianis&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B25">L. M. Coussens and Z. Werb, Matrix metalloproteinases and the development of cancer, <i>Chemistry and Biology</i>, vol. 3, no. 11, pp. 895904, 1996. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases%20and%20the%20development%20of%20cancer&author=L. M. Coussens &author=Z. Werb&publication_year=1996" target="_blank">Google Scholar</a></span><li id="B26">M. H. Chien, C. W. Lin, C. W. Cheng, Y. C. Wen, and S. F. Yang, Matrix metalloproteinase (MMP)-2 as a target for head and neck cancer therapy, <i>Expert Opinion on Therapeutic Targets</i>. In press. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase%20(MMP)-2%20as%20a%20target%20for%20head%20and%20neck%20cancer%20therapy&author=M. H. Chien&author=C. W. Lin&author=C. W. Cheng&author=Y. C. Wen&author=&author=S. F. Yang" target="_blank">Google Scholar</a></span><li id="B27">A. Katayama, N. Bandoh, K. Kishibe et al., Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis, <i>Clinical Cancer Research</i>, vol. 10, no. 2, pp. 634640, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1158/1078-0432.CCR-0864-02">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Expressions%20of%20matrix%20metalloproteinases%20in%20early-stage%20oral%20squamous%20cell%20carcinoma%20as%20predictive%20indicators%20for%20tumor%20metastases%20and%20prognosis&author=A. Katayama&author=N. Bandoh&author=K. Kishibe et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B28">S. Kurahara, M. Shinohara, T. Ikebe et al., Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis, <i>Head &#x26; Neck</i>, vol. 21, pp. 627638, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Expression%20of%20MMPS,%20MT-MMP,%20and%20TIMPs%20in%20squamous%20cell%20carcinoma%20of%20the%20oral%20cavity:%20correlations%20with%20tumor%20invasion%20and%20metastasis&author=S. Kurahara&author=M. Shinohara&author=T. Ikebe et al.&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B29">H. Qin, Y. Sun, and E. N. Benveniste, The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells, <i>Journal of Biological Chemistry</i>, vol. 274, no. 41, pp. 2913029137, 1999. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.274.41.29130">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20transcription%20factors%20Sp1,%20Sp3,%20and%20AP-2%20are%20required%20for%20constitutive%20matrix%20metalloproteinase-2%20gene%20expression%20in%20astroglioma%20cells&author=H. Qin&author=Y. Sun&author=&author=E. N. Benveniste&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B30">P. A. M. Snoek-van Beurden and J. W. Von Den Hoff, Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors, <i>BioTechniques</i>, vol. 38, no. 1, pp. 7383, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Zymographic%20techniques%20for%20the%20analysis%20of%20matrix%20metalloproteinases%20and%20their%20inhibitors&author=P. A. M. Snoek-van Beurden &author=J. W. Von Den Hoff&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B31">R. K. Nuttall, C. J. Pennington, J. Taplin et al., Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells, <i>Molecular Cancer Research</i>, vol. 1, no. 5, pp. 333345, 2003. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Elevated%20membrane-type%20matrix%20metalloproteinases%20in%20gliomas%20revealed%20by%20profiling%20proteases%20and%20inhibitors%20in%20human%20cancer%20cells&author=R. K. Nuttall&author=C. J. Pennington&author=J. Taplin et al.&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B32">S. Imren, D. B. Kohn, H. Shimada, L. Blavier, and Y. A. DeClerck, Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion, <i>Cancer Research</i>, vol. 56, no. 13, pp. 28912895, 1996. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Overexpression%20of%20tissue%20inhibitor%20of%20metalloproteinases-2%20by%20retroviral-mediated%20gene%20transfer%20in%20vivo%20inhibits%20tumor%20growth%20and%20invasion&author=S. Imren&author=D. B. Kohn&author=H. Shimada&author=L. Blavier&author=&author=Y. A. DeClerck&publication_year=1996" target="_blank">Google Scholar</a></span><li id="B33">P. Valente, G. Fassina, A. Melchiori et al., TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis, <i>International Journal of Cancer</i>, vol. 75, pp. 246253, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=TIMP-2%20over-expression%20reduces%20invasion%20and%20angiogenesis%20and%20protects%20B16F10%20melanoma%20cells%20from%20apoptosis&author=P. Valente&author=G. Fassina&author=A. Melchiori et al.&publication_year=1998" target="_blank">Google Scholar</a></span><li id="B34">D. W. Visscher, M. H&#xf6;yhty&#xe4;, S. K. Ottosen et al., Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence, <i>International Journal of Cancer</i>, vol. 59, no. 3, pp. 339344, 1994. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ijc.2910590308">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Enhanced%20expression%20of%20tissue%20inhibitor%20of%20metalloproteinase-2%20(TIMP-2)%20in%20the%20stroma%20of%20breast%20carcinomas%20correlates%20with%20tumor%20recurrence&author=D. W. Visscher&author=M. Hyhty&author=S. K. Ottosen et al.&publication_year=1994" target="_blank">Google Scholar</a></span><li id="B35">P. N. Chen, Y. S. Hsieh, H. L. Chiou, and S. C. Chu, Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways, <i>Chemico-Biological Interactions</i>, vol. 156, no. 2-3, pp. 141150, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cbi.2005.08.005">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Silibinin%20inhibits%20cell%20invasion%20through%20inactivation%20of%20both%20PI3K-Akt%20and%20MAPK%20signaling%20pathways&author=P. N. Chen&author=Y. S. Hsieh&author=H. L. Chiou&author=&author=S. C. Chu&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B36">Y. S. Hsieh, S. C. Chu, S. F. Yang, P. N. Chen, Y. C. Liu, and K. H. Lu, Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2, <i>Carcinogenesis</i>, vol. 28, no. 5, pp. 977987, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1093/carcin/bgl221">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Silibinin%20suppresses%20human%20osteosarcoma%20MG-63%20cell%20invasion%20by%20inhibiting%20the%20ERK-dependent%20c-Jun/AP-1%20induction%20of%20MMP-2&author=Y. S. Hsieh&author=S. C. Chu&author=S. F. Yang&author=P. N. Chen&author=Y. C. Liu&author=&author=K. H. Lu&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B37">C. J. Weng, C. F. Chau, Y. S. Hsieh, S. F. Yang, and G. C. Yen, Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-<i>&#x3ba;</i>B and AP-1, <i>Carcinogenesis</i>, vol. 29, no. 1, pp. 147156, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1093/carcin/bgm261">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Lucidenic%20acid%20inhibits%20PMA-induced%20invasion%20of%20human%20hepatoma%20cells%20through%20inactivating%20MAPK/ERK%20signal%20transduction%20pathway%20and%20reducing%20binding%20activities%20of%20NF-B%20and%20AP-1&author=C. J. Weng&author=C. F. Chau&author=Y. S. Hsieh&author=S. F. Yang&author=&author=G. C. Yen&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B38">C. Huang, K. Jacobson, and M. D. Schaller, MAP kinases and cell migration, <i>Journal of Cell Science</i>, vol. 117, no. 20, pp. 46194628, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1242/jcs.01481">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=MAP%20kinases%20and%20cell%20migration&author=C. Huang&author=K. Jacobson&author=&author=M. D. Schaller&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B39">Z. Huang, D. P. Yan, and B. X. Ge, JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin, <i>Cellular Signalling</i>, vol. 20, no. 11, pp. 20022012, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cellsig.2008.07.014">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=JNK%20regulates%20cell%20migration%20through%20promotion%20of%20tyrosine%20phosphorylation%20of%20paxillin&author=Z. Huang&author=D. P. Yan&author=&author=B. X. Ge&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B40">O. Fromigu&#xe9;, Z. Hamidouche, and P. J. Marie, Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, <i>Journal of Biological Chemistry</i>, vol. 283, no. 45, pp. 3054930556, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M801436200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Blockade%20of%20the%20RhoA-JNK-c-Jun-MMP2%20cascade%20by%20atorvastatin%20reduces%20osteosarcoma%20cell%20invasion&author=O. Fromigu&author=Z. Hamidouche&author=&author=P. J. Marie&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B41">J. Zhong, M. M. C. Gencay, L. Bubendorf et al., ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells, <i>Journal of Cellular Physiology</i>, vol. 207, no. 2, pp. 540552, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jcp.20605">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=ERK1/2%20and%20p38%20MAP%20kinase%20control%20MMP-2,%20MT1-MMP,%20and%20TIMP%20action%20and%20affect%20cell%20migration:%20a%20comparison%20between%20mesothelioma%20and%20mesothelial%20cells&author=J. Zhong&author=M. M. C. Gencay&author=L. Bubendorf et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B42">B. Kumar, S. Koul, J. Petersen et al., p38 Mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity, <i>Cancer Research</i>, vol. 70, no. 2, pp. 832841, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1158/0008-5472.CAN-09-2918">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=p38%20Mitogen-activated%20protein%20kinase-driven%20MAPKAPK2%20regulates%20invasion%20of%20bladder%20cancer%20by%20modulation%20of%20MMP-2%20and%20MMP-9%20activity&author=B. Kumar&author=S. Koul&author=J. Petersen et al.&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B43">T. Tian, K. J. Nan, H. Guo et al., PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway, <i>Oncology Reports</i>, vol. 23, no. 6, pp. 15931600, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.3892/or&amp;#x5f;00000800">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=PTEN%20inhibits%20the%20migration%20and%20invasion%20of%20HepG2%20cells%20by%20coordinately%20decreasing%20MMP%20expression%20via%20the%20PI3K/Akt%20pathway&author=T. Tian&author=K. J. Nan&author=H. Guo et al.&publication_year=2010" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright &#xa9; 2012 Chih-Yu Peng et al. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 eyHfWh journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 dbAANp article_widget biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">More related articles</h4><div id="biblio_widget" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 jzTMLK rightWrapper" id="rightSectionMenu"><div><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 gbrQxi article_sticky_top_toolbar"><div class="sc-cBdUnI hRnXob article_top_toolbar"><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-exkUMo hymroZ pdf_desktop button__group" href="https://downloads.hindawi.com/journals/ecam/2012/732578.pdf" aria-label="" target="_blank" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/><span class="text">PDF</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-kcDeIU cbcyj ref_desktop" href="/journals/ecam/2012/732578.ris" aria-label="" target="" id="toolbar__dcNavLarge"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Download Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-BngTV hmDWcT ref_desktop" href="/journals/ecam/2012/732578.ris" aria-label="" target="" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 isgRZA article_sticky_bottom_toolbar"><div class="sc-cTjmhe ihmyEq article_bottom_toolbar"><div class="sc-cugefK itFKcQ accordion" property="background-color" color="#D8D8D8" id="toolbar__dofNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMjAiIGhlaWdodD0iMjIiIHZpZXdCb3g9IjAgMCAyMCAyMiI+PGRlZnM+PGNsaXBQYXRoIGlkPSJhIj48cGF0aCBkPSJNMywyMmEzLDMsMCwwLDEtMy0zVjE2YTEsMSwwLDAsMSwyLDB2M2ExLDEsMCwwLDAsMSwxSDE3YTEsMSwwLDAsMCwxLTFWMTZhMSwxLDAsMSwxLDIsMHYzYTMsMywwLDAsMS0zLDNabTYuMjg4LTYuMy00LTRhMSwxLDAsMCwxLDEuNDE0LTEuNDE0TDksMTIuNTg2VjFhMSwxLDAsMCwxLDIsMFYxMi41ODZsMi4yOTMtMi4yOTNhMSwxLDAsMCwxLDEuNDE0LDEuNDE0bC00LDRhMSwxLDAsMCwxLTEuNDIzLDBaIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgyIDEpIi8+PC9jbGlwUGF0aD48L2RlZnM+PGcgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTIgLTEpIj48cGF0aCBkPSJNMywyMmEzLDMsMCwwLDEtMy0zVjE2YTEsMSwwLDAsMSwyLDB2M2ExLDEsMCwwLDAsMSwxSDE3YTEsMSwwLDAsMCwxLTFWMTZhMSwxLDAsMSwxLDIsMHYzYTMsMywwLDAsMS0zLDNabTYuMjg4LTYuMy00LTRhMSwxLDAsMCwxLDEuNDE0LTEuNDE0TDksMTIuNTg2VjFhMSwxLDAsMCwxLDIsMFYxMi41ODZsMi4yOTMtMi4yOTNhMSwxLDAsMCwxLDEuNDE0LDEuNDE0bC00LDRhMSwxLDAsMCwxLTEuNDIzLDBaIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgyIDEpIi8+PGcgY2xpcC1wYXRoPSJ1cmwoI2EpIj48cmVjdCB3aWR0aD0iMjQiIGhlaWdodD0iMjQiIGZpbGw9InJnYmEoMCwwLDAsMCkiLz48cmVjdCB3aWR0aD0iMjQiIGhlaWdodD0iMjQiLz48L2c+PC9nPjwvc3ZnPg==" height="24"/><span class="sc-dRFtgE jrsDZP">Download other formats</span><span class="sc-gkFcWv gWTCXQ">More</span></span><span class="sc-htoDjs bMdQcY sc-gbOuXE jGPvPL icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="11"></span></div><div class="sc-fnwBNb etzuBr"><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2012/732578.epub" aria-label="ePub" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">ePub</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/ecam/2012/732578.xml" aria-label="XML" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">XML</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><a class="sc-htpNat bUhGXt link sc-imABML ibWUzs" href="https://reprints.hindawi.com/732578/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8" id="toolbar__opcNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Order printed copies</span><span class="sc-gkFcWv gWTCXQ">Order</span></span><span class="sc-htoDjs kNoiZu sc-gbOuXE jGPvPL right__icon icon-colored _32KP5uexH-Bgs7Kj8Gk1Tz icon-themeable" title="" font-size="16"></span></a><div class="sc-hBbWxd kdRRST"><div class="sc-dyGzUR cHatnS"><div>Views<span>1730</span></div><div>Downloads<span>1123</span></div></div><div><div class="sc-drKuOJ kxdGAZ"><span class="__dimensions_badge_embed__" data-doi="10.1155/2012/732578" data-style="small_circle"></span>Citations</div></div></div><nav class="sc-bRBYWo fXBKFa sc-hUfwpO jHPgUP" id="toolbar__iconNav"><h3 class="sc-Rmtcm hNPrIr">Share Post</h3><ul class="sc-hzDkRC bnbfTS"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2012/732578&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialTwitter" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2012/732578" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialLinkedin" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialLinkedin.svg" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2012/732578" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialFacebook" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialFacebook-HINDAWI.svg" height="24"/></a></li><li class="iconBorder"><div class="wechat-container"><img alt=" " class="sc-EHOje jOLhQl socialWechat" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><div class="addthis_inline_share_toolbox"></div><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5ec5076f7164b9b5"></script></div></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway&amp;body=https://doi.org/10.1155/2012/732578" aria-label="Sharing on Mail" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialMail" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li></ul></nav></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 cBTaXT journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 cYsVdk biblioWrapperRight biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">Related articles</h4><div id="biblio_sidebar" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div></div></div></main><footer class="sc-jKJlTe inBNwS"><section class="sc-eNQAEJ dkutRV"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-hMqMXs hlGpbO mobile">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNDAiIGhlaWdodD0iNDAiIHZpZXdCb3g9IjAgMCA0MCA0MCIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBmaWxsLXJ1bGU9ImV2ZW5vZGQiIGNsaXAtcnVsZT0iZXZlbm9kZCIgZD0iTTAgMjBDMCA4Ljk1NTk5IDguOTU1OTkgMCAyMCAwQzMxLjA0NCAwIDQwIDguOTU1OTkgNDAgMjBDNDAgMzEuMDQ0IDMxLjA0NCA0MCAyMCA0MEM4Ljk1NTk5IDQwIDAgMzEuMDQ0IDAgMjBaTTkuMzE3MzIgMzAuMjM0NEgxNC4xODgyVjE1LjU4MDFIOS4zMTczMlYzMC4yMzQ0Wk0xMS43NTI5IDEzLjU3OTFIMTEuNzIxMkMxMC4wODY3IDEzLjU3OTEgOS4wMjk1NCAxMi40NTM5IDkuMDI5NTQgMTEuMDQ3N0M5LjAyOTU0IDkuNjA5NjggMTAuMTE5IDguNTE1NjIgMTEuNzg1MyA4LjUxNTYyQzEzLjQ1MTUgOC41MTU2MiAxNC40NzY5IDkuNjA5NjggMTQuNTA4NyAxMS4wNDc3QzE0LjUwODcgMTIuNDUzOSAxMy40NTE1IDEzLjU3OTEgMTEuNzUyOSAxMy41NzkxWk0yNi44ODE0IDMwLjIzNDRIMzEuNzUxN1YyMS44MzE3QzMxLjc1MTcgMTcuMzMwNiAyOS4zNDg4IDE1LjIzNjIgMjYuMTQ0MSAxNS4yMzYyQzIzLjU1OTkgMTUuMjM2MiAyMi40MDE3IDE2LjY1NjUgMjEuNzU0NSAxNy42NTVWMTUuNTgwMUgxNi44ODM5QzE2Ljk0NzYgMTYuOTU1IDE2Ljg4MzkgMzAuMjM0NCAxNi44ODM5IDMwLjIzNDRIMjEuNzU0NVYyMi4wNTA4QzIxLjc1NDUgMjEuNjEyOSAyMS43ODU5IDIxLjE3NTIgMjEuOTE0NyAyMC44NjIxQzIyLjI2NjggMTkuOTg3MiAyMy4wNjgyIDE5LjA4MDggMjQuNDEzOCAxOS4wODA4QzI2LjE3NjEgMTkuMDgwOCAyNi44ODE0IDIwLjQyNDUgMjYuODgxNCAyMi4zOTQ3VjMwLjIzNDRaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PC9zdmc+" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="/about/" aria-label="About us">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="/about/contact/" aria-label="Contact us">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="/publishing-partnerships/" aria-label="Partnerships">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="/blog/" aria-label="Blog">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="/journals/" aria-label="Journals">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link print_editions" href="/print-editions/" aria-label="Print editions">Print editions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="/publish-research/authors/" aria-label="Authors">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="/publish-research/editors/" aria-label="Editors">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="/publish-research/reviewers/" aria-label="Reviewers">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="/open-archives-initiative/" aria-label="Open Archives Initiative">Open Archives Initiative</a></li><li><a class="sc-htpNat bUhGXt link fraud_prevention" href="/preventing-and-protecting-against-fraud/" aria-label="Fraud prevention">Fraud prevention</a></li></ul></nav><div class="sc-hMqMXs hlGpbO desktop">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-iAyFgw gCiATD"><a class="sc-htpNat bUhGXt link" href="/privacy/" aria-label="Privacy Policy">Privacy Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/terms/" aria-label="Terms of Service">Terms of Service<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/responsible-disclosure-policy/" aria-label="Responsible Disclosure Policy">Responsible Disclosure Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/cookie-policy/" aria-label="Cookie Policy">Cookie Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/copyright/" aria-label="Copyright">Copyright<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/modern-slavery-statement/" aria-label="Modern slavery statement">Modern slavery statement<!-- --> </a></section></div></footer><div class="sc-OxbzP eEFYIL  advWrapper hideBanner"><span><p>Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.&nbsp;<a href="https://www.hindawi.com/article-year-award/" rel="noopener noreferrer" target="_blank">Read the winning articles</a>.</p>
</span><button class="sc-bYnzgO dsXEHZ"><img alt=" " class="sc-EHOje iiusBg sc-cPuPxo iXKuYd" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></button></div></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues","pe":"/publish-research/authors/publication-ethics","fr":"/publish-research/reviewers","fe":"/publish-research/editors"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://review.hindawi.com/submit?journal={journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to\u0026nbsp;\u003ca href=\"mailto:{journal_subcode}@hindawi.com\"\u003e{journal_subcode}@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eGeneral enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\r\n"},"open_access":{"title":"Open Access","text":"\u003cp dir=\"ltr\"\u003e\u003cem\u003e{journal_name}\u003c/em\u003e is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our \u003ca href=\"https://www.hindawi.com/copyright/\"\u003ecopyright page\u003c/a\u003e.\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","theme":"HINDAWI","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","social_share_options":["facebook","twitter","linkedin","wechat","mail"],"use_journal_etoc_pages":true,"GTM_ID":"GTM-MQ4MGW","SITE_NAME":"Hindawi","secureSiteUrl":"https://www.hindawi.com","features":{"isMaintenanceOn":false},"useLazyLoad":false,"hasJournalReportPage":false},"data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2019-10/ECAM_hero.jpg?itok=9epnhPpu","alt":"Evidence-Based Complementary and Alternative Medicine"},"text_colour_code":"#ffffff","about_journal":"/journals/ecam/about","is_wiley_partner":0,"metrics_data":{"id":6699,"title":"Evidence-Based Complementary and Alternative Medicine","url":"/journals/ecam","apc":{"label":"APC","value":"$2550","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/ecam/ecam.banner.small.jpg","alt":"Evidence-Based Complementary and Alternative Medicine"},"metrics":[{"label":"Acceptance rate","value":"27%"},{"label":"Submission to final decision","value":"68 days"},{"label":"Acceptance to publication","value":"33 days"},{"label":"CiteScore","value":"3.000"},{"label":"Journal Citation Indicator","value":"0.730"},{"label":"Impact Factor","value":"2.629"}],"logos":[],"toolbar_metrics_or_logo":"metrics","partner_link":false},"links_block":[{"title":"Author guidelines","link":"/journals/ecam/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/ecam/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/ecam/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":0,"journal_subcode":"ecam","journal_issn":"1741-427X","hide_marketing_msg":0,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/ecam/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eEvidence-Based Complementary and Alternative Medicine\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/ecam/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/ecam/osi"}},"meta_info":{"title":"Evidence-Based Complementary and Alternative Medicine | Hindawi","meta_data":[{"name":"title","content":"Evidence-Based Complementary and Alternative Medicine | Hindawi"},{"name":"description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:site_name","content":"Hindawi"},{"property":"og:url","content":"current_url"},{"property":"og:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"property":"og:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:description","content":"Evidence-Based Complementary and Alternative Medicine seeks to apply scientific rigor to the study of complementary and alternative medicine, emphasizing on health outcome, while documenting biological mechanisms of action."},{"name":"twitter:site","content":"Hindawi"},{"name":"twitter:title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"twitter:url","content":"current_url"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"}]},"journal_header_uses_logo":false,"global_manuscript_link":"https://review.hindawi.com/submit?journal=ecam","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null}},"meta":{"meta_data":[{"name":"title","content":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"},{"rel":"canonical","href":"https://www.hindawi.com/journals/ecam/2012/732578/"},{"name":"description","content":"Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM to 40\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/ecam/ecam.banner.jpg"},{"name":"twitter:title","content":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"},{"property":"og:description","content":"Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM to 40\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."},{"name":"twitter:description","content":"Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM to 40\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."},{"name":"citation_title","content":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"},{"name":"citation_author","content":"Peng, Chih-Yu"},{"name":"citation_author","content":"Yang, Hui-Wen"},{"name":"citation_author","content":"Chu, Yin-Hung"},{"name":"citation_author","content":"Chang, Yu-Chao"},{"name":"citation_author","content":"Hsieh, Ming-Ju"},{"name":"citation_author","content":"Chou, Ming-Yung"},{"name":"citation_author","content":"Yeh, Kun-Tu"},{"name":"citation_author","content":"Lin, Yueh-Min"},{"name":"citation_author","content":"Yang, Shun-Fa"},{"name":"citation_author","content":"Lin, Chiao-Wen"},{"name":"citation_journal_title","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2012},{"name":"citation_year","content":"2012"},{"name":"citation_date","content":"2012/12/18"},{"name":"citation_online_date","content":"2012/12/18"},{"name":"citation_doi","content":"https://doi.org/10.1155/2012/732578"},{"name":"citation_issn","content":"1741-427X"},{"name":"citation_abstract","content":"Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM to 40\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_pdf_url","content":"https://downloads.hindawi.com/journals/ecam/2012/732578.pdf"},{"name":"citation_xml_url","content":"https://downloads.hindawi.com/journals/ecam/2012/732578.xml"},{"name":"dc.creator","content":"Peng, Chih-Yu"},{"name":"dc.creator","content":"Yang, Hui-Wen"},{"name":"dc.creator","content":"Chu, Yin-Hung"},{"name":"dc.creator","content":"Chang, Yu-Chao"},{"name":"dc.creator","content":"Hsieh, Ming-Ju"},{"name":"dc.creator","content":"Chou, Ming-Yung"},{"name":"dc.creator","content":"Yeh, Kun-Tu"},{"name":"dc.creator","content":"Lin, Yueh-Min"},{"name":"dc.creator","content":"Yang, Shun-Fa"},{"name":"dc.creator","content":"Lin, Chiao-Wen"},{"name":"dc.title","content":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway"},{"name":"dc.description","content":"Caffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM to 40\u0026#x2009;\u003ci\u003e\u0026#x3bc;\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2012/732578"},{"name":"dc.type","content":"Research Article"},{"name":"dc.date","content":"2012/12/18"},{"name":"dcterms.issued","content":"2012/12/18"},{"name":"prism.publicationDate","content":"2012/12/18"},{"name":"prism.volume","content":2012},{"name":"prism.section","content":"Research Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2012/732578"},{"name":"prism.issn","content":"1741-427X"},{"name":"dc.source","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"prism.publicationName","content":"Evidence-Based Complementary and Alternative Medicine"},{"name":"authors","content":"Chih-Yu Peng | Hui-Wen Yang | ... | Chiao-Wen Lin"}],"title":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway","current_url":"https://www.hindawi.com/journals/ecam/2012/732578/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Print editions","external":0,"relative":"/print-editions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1},{"title":"Fraud prevention","external":0,"relative":"/preventing-and-protecting-against-fraud","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Responsible Disclosure Policy","external":0,"relative":"/responsible-disclosure-policy","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":1},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1},{"title":"Modern slavery statement","external":0,"relative":"/modern-slavery-statement","expanded":0,"enabled":1}]},"config":{"footer_config_logo":"","footer_config_copyright":""}},"headers":{},"journalCode":"ecam"},"isLiveUrl":true,"advMsg":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/ecam/2012/732578/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","headerData":{"status":200,"data":{"header_menu_items":{"header-menu":[{"title":"Journals","external":0,"link":"/journals","expanded":0,"enabled":1},{"title":"Publish with us","external":0,"link":"/publish-research","expanded":0,"enabled":1},{"title":"Publishing partnerships","external":0,"link":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"About us","external":0,"link":"/about","expanded":0,"enabled":1},{"title":"Blog","external":0,"link":"/blog","expanded":0,"enabled":1}]}},"headers":{}},"theme":"HINDAWI","sharingOptions":["facebook","twitter","linkedin","wechat","mail"],"useJournalEtocPages":true,"isUserFromChina":false,"useLazyLoad":false,"hasJournalReportPage":false},"ceased":false,"journalAlias":"/journals/ecam","journalNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/ecam/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/ecam/about","key":"about"},{"title":"Editorial Board","link":"/journals/ecam/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/ecam/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/ecam/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/ecam/apc","key":"apc"}]},{"title":"For authors","link":"/journals/ecam/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/ecam/contents/year/2022","children":[]},{"title":"Special Issues","link":"/journals/ecam/si","children":[{"title":"Open Special Issues","link":"/journals/ecam/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/ecam/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/ecam","article":{"retracted":false,"related_articles":[{"title":"Research Article","link":"/journals/ecam/2012/732578/","childrens":[]},{"title":"Corrigendum","link":"/journals/ecam/2016/6728642","childrens":[{"special_issue":false,"volume":"2016","pdf":"downloads.hindawi.com/journals/ecam/2016/6728642.pdf","abstract":"","id":"6728642","type":"Corrigendum","title":"Corrigendum to \u0026#x201c;Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway\u0026#x201d;","date":"28 Jun 2016","journal":"Evidence-Based Complementary and Alternative Medicine","alias":"/journals/ecam/2016/6728642","authors":[{"name":"Chih-Yu Peng"},{"name":"Hui-Wen Yang"},{"name":"Yin-Hung Chu"},{"name":"Yu-Chao Chang"},{"name":"Ming-Ju Hsieh"},{"name":"Ming-Yung Chou"},{"name":"Kun-Tu Yeh"},{"name":"Yueh-Min Lin"},{"name":"Shun-Fa Yang"},{"name":"Chiao-Wen Lin"}],"reference":"/journals/ecam/2016/6728642.ris"}]}],"id":"732578","title":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway","title_toc":"Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway","type":"Research Article","volume":2012,"pub_year":"2012","article_id":"732578","pages":10,"first_page":"","last_page":"","issue_no":"","doi":"https://doi.org/10.1155/2012/732578","doi_simple":"10.1155/2012/732578","shorten_url":"https://doi.org/10.1155/2012/732578","inPress":false,"academic_editors":[{"name":"Shrikant Anant"}],"guest_editors":[],"published_date":"18 Dec 2012","received_date":"30 Sep 2012","revised_date":"10 Nov 2012","accepted_date":"19 Nov 2012","authors":[{"name":"Chih-Yu Peng","email":"","orcid":"","sup":["1","2"]},{"name":"Hui-Wen Yang","email":"","orcid":"","sup":["1","2"]},{"name":"Yin-Hung Chu","email":"","orcid":"","sup":["3"]},{"name":"Yu-Chao Chang","email":"","orcid":"","sup":["1","2"]},{"name":"Ming-Ju Hsieh","email":"","orcid":"","sup":["4"]},{"name":"Ming-Yung Chou","email":"","orcid":"","sup":["1","2"]},{"name":"Kun-Tu Yeh","email":"","orcid":"","sup":["5"]},{"name":"Yueh-Min Lin","email":"","orcid":"","sup":["5"]},{"name":"Shun-Fa Yang","email":"wt.ude.umsc@fsy","orcid":"","sup":["3","6"]},{"name":"Chiao-Wen Lin","email":"wt.ude.umsc@nilwc","orcid":"","sup":["2","7"]}],"affiliations":[{"id":"1","text":"School of Dentistry, Chung Shan Medical University, Taichung 40201, Taiwan"},{"id":"2","text":"Department of Dentistry, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"},{"id":"3","text":"Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"},{"id":"4","text":"School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan"},{"id":"5","text":"Department of Pathology, Changhua Christian Hospital, Changhua 50006, Taiwan"},{"id":"6","text":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"},{"id":"7","text":"Institute of Oral Sciences, Chung Shan Medical University, Taichung 40201, Taiwan"}],"is_special_issue":0,"special_issue_details":{"title":"","url":""},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eCaffeic acid phenethyl ester (CAPE), an active component extracted from honeybee hives, exhibits anti-inflammatory and anticancer activities. However, the molecular mechanism by which CAPE affects oral cancer cell metastasis has yet to be elucidated. In this study, we investigated the potential mechanisms underlying the effects of CAPE on the invasive ability of SCC-9 oral cancer cells. Results showed that CAPE attenuated SCC-9 cell migration and invasion at noncytotoxic concentrations (0\u003ci\u003e\u003c/i\u003eM to 40\u003ci\u003e\u003c/i\u003eM). Western blot and gelatin zymography analysis findings further indicated that CAPE downregulated matrix metalloproteinase-2 (MMP-2) protein expression and inhibited its enzymatic activity. CAPE exerted its inhibitory effects on MMP-2 expression and activity by upregulating tissue inhibitor of metalloproteinase-2 (TIMP-2) and potently decreased migration by reducing focal adhesion kinase (FAK) phosphorylation and the activation of its downstream signaling molecules p38/MAPK and JNK. These data indicate that CAPE could potentially be used as a chemoagent to prevent oral cancer metastasis.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003eOral cancer is associated with a high degree of local invasiveness and a high rate of metastasis to regional cervical lymph nodes. Oral squamous cell carcinoma (OSCC) is the most common head and neck cancer and is characterized by poor prognosis and low survival rate [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. Metastasis is the major cause of cancer death and involves multiple processes including the remodeling and degradation of the extracellular matrix (ECM) [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. Various proteinases, such as the matrix metalloproteinases (MMPs), cathepsins, and plasminogen activator (PA), are involved in the interactions between cancer cells and the ECM [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e, \u003ca href=\"#B4\"\u003e4\u003c/a\u003e]. The MMPs function in the degradation of structural proteins in the ECM and regulate several cellular functions including growth, invasion, metastasis, and angiogenesis [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e]. Among the various MMPs thought to be involved in human disease, investigators have intensively investigated the gelatinases (MMP-2 and MMP-9). Matrix metalloproteinase-2 and MMP-9 are the principal enzymes involved in the degradation of the major structural component of the basement membrane, type IV collagen [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e, \u003ca href=\"#B7\"\u003e7\u003c/a\u003e]. Several studies have shown that the gelatinases are overexpressed in several types of human cancer, such as breast [\u003ca href=\"#B8\"\u003e8\u003c/a\u003e], pancreas [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e], prostate [\u003ca href=\"#B10\"\u003e10\u003c/a\u003e], lung [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e], and oral [\u003ca href=\"#B12\"\u003e12\u003c/a\u003e] cancers. Previous studies have also identified significantly increased urine and plasma MMP-2 concentrations in cancer patients [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e, \u003ca href=\"#B14\"\u003e14\u003c/a\u003e], with MMP-2 and MMP-9 being considered as predictors of risk or recurrence of metastasis or as cancer prognostic markers [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eCaffeic acid phenethyl ester (CAPE) is one of the active components of honeybee propolis extracts [\u003ca href=\"#B16\"\u003e16\u003c/a\u003e]. Previous research has shown that CAPE exerts antioxidative, anti-inflammatory, and anticancer activities [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. In addition, CAPE suppresses eicosanoid synthesis and inhibits the release of arachidonic acid from cell membranes [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e, \u003ca href=\"#B18\"\u003e18\u003c/a\u003e]. Its anti-inflammatory activity is derived from the downregulation of COX-2 expression [\u003ca href=\"#B19\"\u003e19\u003c/a\u003e, \u003ca href=\"#B20\"\u003e20\u003c/a\u003e]. Chuu et al. identified that CAPE suppressed human prostate cancer cell proliferation through the inhibition of Akt [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e]. Other studies have shown that CAPE induced apoptosis through the activation of Fas and Bax and the inhibition of NF-\u003csvg height=\"7.9499998\" id=\"M1\" style=\"vertical-align:-0.1638pt;width:8.7375002px;\" version=\"1.1\" viewbox=\"0 0 8.7375002 7.9499998\" width=\"8.7375002\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,7.675)\"\u003e\u003cpath d=\"M484 406q0 -21 -22 -38q-10 -7 -18 -1q-15 11 -30 11q-30 0 -77.5 -37t-74.5 -67l79 -168q11 -23 19.5 -34.5t13 -14t10.5 -2.5q9 0 30 17.5t40 42.5l17 -23q-31 -45 -57.5 -69.5t-40.5 -29.5t-31 -5q-18 0 -32 13.5t-35 55.5q-34 71 -69 160q-36 -32 -59 -56\u0026#10;q-12 -27 -36 -158q-44 -7 -77 -15l-5 7l82 349q6 25 -2 25q-16 0 -72 -41l-14 22q44 41 89 69.5t66 28.5q19 0 19 -32q0 -16 -6 -43l-35 -160l146 143q94 92 136 92q20 0 33 -12t13 -30z\" id=\"x1D705\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003eB [\u003ca href=\"#B22\"\u003e22\u003c/a\u003e, \u003ca href=\"#B23\"\u003e23\u003c/a\u003e]. However, its effects on OSCC invasion and metastasis and their underlying mechanisms have yet to be fully elucidated.\u003c/p\u003e\u003cp\u003eThis study investigated the association between CAPE treatment and invasion of SCC-9 oral cancer cells. Our results showed that CAPE suppressed the migration and invasion of oral cancer cells, probably through the inhibition of FAK phosphorylation and its downstream p38 and JNK signaling pathways. Results also indicated that the anti-invasive activity of CAPE is partly mediated by the regulation of MMP-2 expression and activity, which reduces the ability of oral cancer cells to degrade components of the extracellular matrix.\u003c/p\u003e\u003ch4 id=\"materials-and-methods\"\u003e2. Materials and Methods\u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Cell Culture and CAPE Treatment\u003c/h5\u003e\u003cp\u003eSCC-9, a human tongue squamous cell carcinoma cell line obtained from ATCC (Manassas, VA, USA), was cultured in Dulbeccos Modified Eagles Medium supplemented with a nutrient mixture, which comprised F-12 Hams medium (Life Technologies, Grand Island, NY, USA), 10% fetal bovine serum (Hyclone Laboratories, Logan, UT, USA), 2mM glutamine, 100U/mL penicillin, and 100\u003ci\u003e\u003c/i\u003eg/mL streptomycin. All cell cultures were maintained at 37C in a humidified atmosphere of 5%CO\u003csub\u003e2\u003c/sub\u003e. For CAPE treatment, appropriate amounts of stock solution of CAPE were added into culture medium to achieve the indicated concentrations and then incubated with cells for indicated time periods, whereas dimethyl sulfoxide solution without CAPE was used as blank reagent.\u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. Determination of Cell Viability (MTT Assay)\u003c/h5\u003e\u003cp\u003eFor cell viability experiment, a microculture tetrazolium (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay was performed to determine the cytotoxicity of CAPE [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. SCC-9 cells were seeded in 24-well plates at a density of \u003csvg height=\"16.012501\" id=\"M2\" style=\"vertical-align:-0.1638pt;width:48.474998px;\" version=\"1.1\" viewbox=\"0 0 48.474998 16.012501\" width=\"48.474998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,15.738)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,11.996,15.738)\"\u003e\u003cpath d=\"M528 54l-36 -38l-198 201l-198 -201l-36 38l197 200l-197 201l36 38l198 -202l198 202l36 -38l-197 -201z\" id=\"xD7\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,25.748,15.738)\"\u003e\u003cpath d=\"M384 0h-275v27q67 5 81.5 18.5t14.5 68.5v385q0 38 -7.5 47.5t-40.5 10.5l-48 2v24q85 15 178 52v-521q0 -55 14.5 -68.5t82.5 -18.5v-27z\" id=\"x31\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,33.907,15.738)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003cg transform=\"matrix(.012,-0,0,-.012,42.075,7.587)\"\u003e\u003cpath d=\"M456 178h-96v-72q0 -51 12.5 -62.5t72.5 -16.5v-27h-256v27q65 5 78 17t13 62v72h-260v28q182 271 300 426h40v-407h96v-47zM280 225v295h-2q-107 -148 -196 -295h198z\" id=\"x34\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e cells/well and treated with CAPE at a concentration between 0 and 40\u003ci\u003e\u003c/i\u003eM at 37C for 24 and 48h. After the exposure period, the media were removed, and cells were washed with phosphate-buffered saline (PBS) and then incubated with 20\u003ci\u003e\u003c/i\u003eL MTT (5mg/mL) (Sigma chemical Co., St. Louis, MO, USA) for 4h. The viable cell number per dish is directly proportional to the production of formazan, which can be measured spectrophotometrically at 563nm following solubilization with isopropanol.\u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Annexin V/PI Double Staining\u003c/h5\u003e\u003cp\u003eAn FITC Annexin V Apoptosis Detection Kit I was used to quantify cell numbers in different stages of cell death. Briefly, \u003csvg height=\"15.9\" id=\"M3\" style=\"vertical-align:-0.1638pt;width:48.474998px;\" version=\"1.1\" viewbox=\"0 0 48.474998 15.9\" width=\"48.474998\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,15.638)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,11.996,15.638)\"\u003e\u003cuse xlink:href=\"#xD7\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,25.748,15.638)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,33.907,15.638)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003cg transform=\"matrix(.012,-0,0,-.012,42.075,7.475)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e cells were resuspended in 100\u003ci\u003e\u003c/i\u003eL 1x binding buffer (0.01M Hepes/NaOH (pH 7.4), 0.14M NaCl, and 2.5mM CaCl\u003csub\u003e2\u003c/sub\u003e). With an addition of 5\u003ci\u003e\u003c/i\u003eL of FITC Annexin V and 5\u003ci\u003e\u003c/i\u003eL PI, the cell suspension was incubated for 15 minutes at room temperature in the dark. Afterwards, 400\u003ci\u003e\u003c/i\u003eL of 1x binding buffer was added to each tube followed by flow cytometry analysis within 1 hour.\u003c/p\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. In Vitro Wound Closure\u003c/h5\u003e\u003cp\u003eSCC-9 cells (1  10\u003csup\u003e5\u003c/sup\u003e cells/well) were plated in 6-well plates for 24h, wounded by scratching with a pipette tip, then incubated with DMEM medium containing 0.5% FBS, and treated with or without CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 0, 24, 48, and 72h. Cells were photographed using a phase-contrast microscope (\u003csvg height=\"11.125\" id=\"M4\" style=\"vertical-align:-0.1638pt;width:34.575001px;\" version=\"1.1\" viewbox=\"0 0 34.575001 11.125\" width=\"34.575001\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cuse xlink:href=\"#xD7\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,10.041,10.862)\"\u003e\u003cuse xlink:href=\"#x31\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,18.2,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,26.36,10.862)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e).\u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Cell Migration and Invasion Assays\u003c/h5\u003e\u003cp\u003eCell migration and invasion were assayed according to the methods described by Yang et al. [\u003ca href=\"#B4\"\u003e4\u003c/a\u003e]. After a treatment with CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 24h, surviving cells were harvested and seeded to Boyden chamber (Neuro Probe, Cabin John, MD, USA) at 10\u003csup\u003e4\u003c/sup\u003ecells/well in serum-free medium and then incubated for 24 hours at 37C. For invasion assay, 10\u003ci\u003e\u003c/i\u003eL Matrigel (25mg/50mL; BD Biosciences, MA, USA) was applied to 8\u003ci\u003e\u003c/i\u003em pore-size polycarbonate membrane filters, and the bottom chamber contained standard medium. Filters were then air-dried for 5h in a laminar flow hood. The invaded cells were fixed with 100% methanol and stained with 5% Giemsa. Cell numbers were counted under a light microscope. The migration assay was carried out as described in the invasion assay with no coating of Matrigel [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e].\u003c/p\u003e\u003ch5 id=\"sec2.6\"\u003e2.6. Determination of MMP-2 by Gelatin Zymography\u003c/h5\u003e\u003cp\u003eThe activities of MMP-2 in conditional medium were measured by gelatin zymography protease assays as previously described [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. Briefly, collected media of an appropriate volume (adjusted by vital cell number) were prepared with SDS sample buffer without boiling or reduction and subjected to 0.1% gelatin and 8% SDS-PAGE electrophoresis. After electrophoresis, gels were washed with 2.5% Triton X-100 and then incubated in reaction buffer (40mM TrisHCl, pH 8.0, 10mM CaCl\u003csub\u003e2\u003c/sub\u003e, and 0.01% NaN\u003csub\u003e3\u003c/sub\u003e) for 12h at 37C. Then the gel was stained with Coomassie Brilliant Blue R-250. \u003c/p\u003e\u003ch5 id=\"sec2.7\"\u003e2.7. Preparation of Total Cell Lysates\u003c/h5\u003e\u003cp\u003eFor total cell lysates preparation, cells were rinsed with PBS twice, scraped with 0.2mL of cold RIPA buffer containing protease inhibitors cocktail, and then vortexed at 4C for 10min. Cell lysates were subjected to a centrifugation of 10,000rpm for 10min at 4C, and the insoluble pellet was discarded. The protein concentration of total cell lysates and nuclear fraction was determined by Bradford assay [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. \u003c/p\u003e\u003ch5 id=\"sec2.8\"\u003e2.8. Western Blot Analysis\u003c/h5\u003e\u003cp\u003eThe cell lysates were separated in a 10% polyacrylamide gel and transferred onto a nitrocellulose membrane. The blot was subsequently incubated with 5% nonfat milk in Tris-buffered saline (20mM Tris, 137mM NaCl, pH 7.6) for 1h to block nonspecific binding and then incubated overnight with polyclonal antibodies against MMP-2, TIMP-2, caspase 3, 8, and 9, three MAPKs (ERK 1/2, JNK 1/2, and p38), Akt, or FAK with the specific antibodies for unphosphorylated or phosphorylated forms of the corresponding ERK 1/2, JNK 1/2, p38, Akt, and FAK. Blots were then incubated with a horseradish peroxidase goat anti-rabbit or anti-mouse IgG for 1h. Afterwards, signal was detected by using enhanced chemiluminescence (ECL) commercial kit (Amersham Biosciences), and relative photographic density was quantitated by scanning the photographic negatives on a gel documentation and analysis system (AlphaImager 2000, Alpha Innotech Corporation, San Leandro, CA, USA).\u003c/p\u003e\u003ch5 id=\"sec2.9\"\u003e2.9. Statistical Analysis\u003c/h5\u003e\u003cp\u003eStatistical significances of difference throughout this study were calculated by Students \u003csvg height=\"10.3875\" id=\"M5\" style=\"vertical-align:-0.1638pt;width:5.9250002px;\" version=\"1.1\" viewbox=\"0 0 5.9250002 10.3875\" width=\"5.9250002\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.125)\"\u003e\u003cpath d=\"M324 430l-26 -36l-112 -4l-55 -265q-13 -66 7 -66q13 0 44.5 20t50.5 40l17 -24q-38 -40 -85.5 -73.5t-87.5 -33.5q-50 0 -21 138l55 262h-80l-2 8l25 34h66l25 99l78 63l10 -9l-37 -153h128z\" id=\"x1D461\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e-test (Sigma-Stat 2.0, Jandel Scientific, San Rafael, CA, USA). A difference at \u003csvg height=\"11.375\" id=\"M6\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e was considered to be statistically significant, and the experiments were repeated three times. \u003c/p\u003e\u003ch4 id=\"results\"\u003e3. Results\u003c/h4\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Effects of CAPE on SCC-9 Cell Viability\u003c/h5\u003e\u003cp\u003e  Figure \u003ca href=\"fig1/#a\" target=\"_blank\"\u003e1(a)\u003c/a\u003e displays the cytotoxic effects of various concentrations of CAPE (0\u003ci\u003e\u003c/i\u003eM40\u003ci\u003e\u003c/i\u003eM) on SCC-9 cells for 24hr and 48hr. Results from MTT assay showed that all concentrations, including the highest tested CAPE concentration (40\u003ci\u003e\u003c/i\u003eM), had nonsignificant effects on SCC-9 cell viability compared to controls (\u003csvg height=\"11.375\" id=\"M7\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 230l-437 -233v58l378 199v2l-378 200v58l437 -233v-51z\" id=\"x3E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e). Furthermore, CAPE also did not alter the cell viability of normal gingival fibroblast at various concentrations (040\u003ci\u003e\u003c/i\u003eM) for 24h (Figure \u003ca href=\"fig1/#b\" target=\"_blank\"\u003e1(b)\u003c/a\u003e). Thus, all subsequent experiments, therefore, used this CAPE concentration range.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig1\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.001a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.001b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig1\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.001a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.001b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig1\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of CAPE on cell viability. (a) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 24h and 48h before being subjected to an MTT assay for cell viability. (b) Normal gingival fibroblast cells were treated with CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 24h before being subjected to an MTT assay for cell viability. The values represented the means  SD of at least three independent experiments. \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eWe further investigated the effect of CAPE on Annexin V flipping and caspase cleavage. Our results showed that treatment of SCC-9 cells with CAPE (040\u003ci\u003e\u003c/i\u003eM) for 24h did not increase the incidence of apoptosis as evidenced without significant changes in the Annexin V/PI double staining (Figure \u003ca href=\"fig2/#a\" target=\"_blank\"\u003e2(a)\u003c/a\u003e) and caspase 3, 8, and 9 expression levels (Figure \u003ca href=\"fig2/#b\" target=\"_blank\"\u003e2(b)\u003c/a\u003e) between control and CAPE-treated SCC-9 cells (\u003csvg height=\"11.375\" id=\"M8\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cuse xlink:href=\"#x3E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e). \u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig2\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig2\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig2\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.002a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.002b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig2\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 2\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig2/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of CAPE on the Annexin V flipping and caspase cleavage in SCC-9 cells. SCC-9 cells were treated with CAPE (040\u003ci\u003e\u003c/i\u003eM) for 24h and then subjected to Annexin V and PI double-stained flow cytometry (a) or Western blotting to analyze the protein levels of caspase 3, 8, and 9 (b).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. Inhibition of SCC-9 Cell Motility, Migration, and Invasion by CAPE\u003c/h5\u003e\u003cp\u003e  In the wound-healing assay, CAPE significantly reduced the cell motility of SCC-9 cells both dose and time dependently (\u003csvg height=\"11.375\" id=\"M9\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) (Figures \u003ca href=\"fig3/#a\" target=\"_blank\"\u003e3(a)\u003c/a\u003e and \u003ca href=\"fig3/#b\" target=\"_blank\"\u003e3(b)\u003c/a\u003e). At 40\u003ci\u003e\u003c/i\u003eM, CAPE decreased the migrated cell number by 38%, 56%, and 82% at 24h, 48h, and 72h, respectively. Using a cell migration and invasion assay with a Boyden chamber, we showed that CAPE reduced SCC-9 cell migration and invasion significantly and in a concentration-dependent manner (\u003csvg height=\"11.375\" id=\"M10\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) (Figures \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e and \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e). In the invasion assay, the inhibition percentage was 1664% (Figure \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e) after incubation of cells with different concentrations (040 \u003ci\u003e\u003c/i\u003eM) of CAPE for 24h. Our results indicated increased inhibition of cell migration with increasing CAPE concentration.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig3\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig3\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig3\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.003a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.003b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig3\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 3\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig3/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of CAPE on in vitro wound closure in oral cancer cells. (a) SCC-9 cells were wounded and then treated with vehicle (DMSO) or CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 0h, 24h, 48h, and 72h in 0.5% FBS-containing medium. At 0, 24h, 48 and 72h, phase-contrast pictures of the wounds at three different locations were taken. (b) Cells migrating into the wound area were counted using the dashed line as time zero. A quantitative assessment of the mean number of cells in the denuded zone is the mean  SD (\u003csvg height=\"11.125\" id=\"M11\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 36.237499 11.125\" width=\"36.237499\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,10.862)\"\u003e\u003cpath d=\"M495 86q-46 -47 -87 -72.5t-63 -25.5q-43 0 -16 107l49 210q7 34 8 50.5t-3 21t-13 4.5q-35 0 -109.5 -72.5t-115.5 -140.5q-21 -75 -38 -159q-50 -10 -76 -21l-6 8l84 340q8 35 -4 35q-17 0 -67 -46l-15 26q44 44 85.5 70.5t64.5 26.5q35 0 10 -103l-24 -98h2\u0026#10;q42 56 97 103.5t96 71.5q46 26 74 26q9 0 16 -2.5t14 -11.5t9.5 -24.5t-1 -44t-13.5 -68.5q-30 -117 -47 -200q-4 -19 -3.5 -25t6.5 -6q21 0 70 48z\" id=\"x1D45B\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,13.305,10.862)\"\u003e\u003cpath d=\"M535 323h-483v50h483v-50zM535 138h-483v50h483v-50z\" id=\"x3D\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,28.008,10.862)\"\u003e\u003cpath d=\"M285 378v-2q65 -13 102 -54.5t37 -97.5q0 -57 -30.5 -104.5t-74 -75t-85.5 -42t-72 -14.5q-31 0 -59.5 11t-40.5 23q-19 18 -16 36q1 16 23 33q13 10 24 0q58 -51 124 -51q55 0 88 40t33 112q0 64 -39 96.5t-88 32.5q-29 0 -64 -11l-6 29q77 25 118 57.5t41 84.5\u0026#10;q0 45 -26.5 69.5t-68.5 24.5q-67 0 -120 -79l-20 20l43 63q51 56 127 56h1q66 0 107 -37t41 -95q0 -42 -31 -71q-22 -23 -68 -54z\" id=\"x33\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig4\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig4\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig4\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.004a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.004b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig4\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 4\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig4/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of CAPE on cell migration and invasion in SCC-9 cells. (a) The cell migration and (b) cell invasion were measured using a Boyden chamber for 16h and 24h with polycarbonate filters, respectively. The migration and invasion abilities of SCC-9 cells were quantified by counting the number of cells that invaded to the underside of the porous polycarbonate as described in Section \u003ca href=\"#sec2\"\u003e2\u003c/a\u003e. The values represented the means  SD of at least three independent experiments. *\u003csvg height=\"11.375\" id=\"M12\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e as compared with the vehicle group. \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Effects of CAPE on MMP-2 and TIMP-2 Protein Expressions and MMP-2 Enzymatic Activity\u003c/h5\u003e\u003cp\u003e   To confirm that MMP-2 plays a vital role in the suppression of cell migration, we compared MMP-2 protein expression in CAPE-treated and control SCC-9 cells. As shown in Figures \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e(a) and \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e(b), treatment of SCC-9 cells with CAPE downregulated MMP-2 enzymatic activity in a concentration-dependent manner (\u003csvg height=\"11.375\" id=\"M13\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e). At 40 \u003ci\u003e\u003c/i\u003eM, CAPE decreased the MMP-2 enzymatic activity by 57% at 24h. CAPE also significantly reduced MMP-2 protein expressions and increased TIMP-2 expression in western blotting (Figures \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e(c) and \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e(d)). CAPE (40\u003ci\u003e\u003c/i\u003eM) increased TIMP-2 expression with about 1.58 folds at 24h.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig5\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig5\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"732578.fig.005\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.005.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 5\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig5/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of CAPE on the activity and protein level of MMP-2 and the protein level of the endogenous inhibitor TIMP-2. (a-b) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40 \u003ci\u003e\u003c/i\u003eM) for 24h and then subjected to gelatin zymography to analyze the activity of MMP-2. (c-d) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 24h and then subjected to western blotting to analyze the protein levels of MMP-2 and TIMP-2. Quantitative results of MMP-2 and TIMP-2 protein levels which were adjusted with \u003csvg height=\"16.6625\" id=\"M14\" style=\"vertical-align:-3.56265pt\" version=\"1.1\" viewbox=\"0 0 10 16.6625\" width=\"10\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,12.162)\"\u003e\u003cpath d=\"M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5\u0026#10;t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z\" id=\"x1D6FD\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e-actin protein level. The values represented the means  SD of at least three independent experiments. *\u003csvg height=\"11.375\" id=\"M15\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e as compared with the vehicle group. \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.4\"\u003e3.4. Effects of CAPE on Focal Adhesion Kinase (FAK) Activation\u003c/h5\u003e\u003cp\u003e   Our investigation of the molecular regulation of cell migration indicated the involvement of FAK in CAPE activity. Having shown that CAPE inhibits SCC-9 cell migration and invasion, we further aimed to evaluate any changes in FAK activation in these cells using antibodies directed against the FAK phosphorylation site Tyr397. As shown in Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e, CAPE reduced FAK phosphorylation in SCC-9 cells. The inhibition percentage was 2042% (Figure \u003ca href=\"fig6/#b\" target=\"_blank\"\u003e6(b)\u003c/a\u003e) after incubation of cells with different concentrations of CAPE for 24h. These results suggested that CAPE inhibits SCC-9 cell migration, at least in part, through the regulation of FAK phosphorylation.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig6\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig6\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.006a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.006b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig6\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.006a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.006b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.006b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig6\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 6\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig6/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of CAPE on the phosphorylation level of FAK. (a) SCC-9 cells were treated with CAPE (0, 5, 10, 20, and 40 \u003ci\u003e\u003c/i\u003eM) for 24h and then subjected to western blotting to analyze the levels of FAK. (b) Quantitative results of phosphorylation level of FAK which were adjusted with total FAK protein level. The values represented the means  SD of at least three independent experiments. *\u003csvg height=\"11.375\" id=\"M16\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e as compared with the vehicle group. \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.5\"\u003e3.5. Effects of CAPE on MAPK and PI3K/Akt Pathways\u003c/h5\u003e\u003cp\u003e   We investigated the effects of CAPE on MAPK and PI3K/Akt pathways using western blot analysis. Results indicated the constitutive phosphorylation of pERK (Figure \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e) and pAKT (Figure \u003ca href=\"fig7/#d\" target=\"_blank\"\u003e7(d)\u003c/a\u003e) in untreated SCC-9 cells and the downregulation of p38 (Figure \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e) and pJNK (Figure \u003ca href=\"fig7/#c\" target=\"_blank\"\u003e7(c)\u003c/a\u003e) phosphorylation in CAPE-treated cells in a dose-dependent manner (\u003csvg height=\"11.375\" id=\"M17\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cuse xlink:href=\"#x3C\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e). At 40\u003ci\u003e\u003c/i\u003eM, CAPE decreased phosphorylation levels of p38 and JNK by 51% and 40%, respectively.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig7\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig7\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.007a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.007b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"732578.fig.007c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"732578.fig.007d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig7\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"732578.fig.007a\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"732578.fig.007b\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"732578.fig.007c\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"732578.fig.007d\" src=\"https://static-01.hindawi.com/articles/ecam/volume-2012/732578/figures/732578.fig.007d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig7\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 7\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig7/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of CAPE on the MAPKs pathway and Akt signalings. SCC-9 cells were cultured in various concentrations of CAPE (0, 5, 10, 20, and 40\u003ci\u003e\u003c/i\u003eM) for 24 hours, and then the cell lysates were subjected to SDS-PAGE followed by western blots with (a) anti-ERK1/2, (b) anti-p38, (c) anti-JNK, and (d) anti-Akt (total and phosphorylated) antibodies as described in Section \u003ca href=\"#sec2\"\u003e2\u003c/a\u003e. Determined activities of these proteins were subsequently quantified by densitometric analyses with that of control being 100% as shown just after the gel data. The values represented the means  SD of at least 3 independent experiments. *\u003csvg height=\"11.375\" id=\"M18\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e as compared with the vehicle group.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch4 id=\"discussion\"\u003e4. Discussion\u003c/h4\u003e\u003cp\u003eThe management of patients with malignant tumors has improved greatly over the past few decades. Patients with OSCC now have an overall 5-year survival rate of approximately 25% [\u003ca href=\"#B24\"\u003e24\u003c/a\u003e]. However, patients with advanced disease often experience cancer spread to local and distant sites, which is poorly controlled by surgery. Our results suggested that CAPE could have potential use as an inhibitor of oral cancer metastasis and could, therefore, facilitate the development of effective anticancer therapies. We identified that CAPE (1) inhibits migration and invasion of SCC-9 oral cancer cells at noncytotoxic concentrations, (2) downregulates MMP-2 protein expression and inhibits its enzymatic activity, (3) increases TIMP-2 expression, (4) inhibits FAK phosphorylation, (5) and inhibits p38 MAPK and JNK activation.\u003c/p\u003e\u003cp\u003eInvasion and migration are considered the most important characteristics of malignant tumors. Solid tumor metastasis is the major cause of death in human cancer patients and involves multiple complicated processes. The degradation of the ECM is considered essential for tumor progression [\u003ca href=\"#B25\"\u003e25\u003c/a\u003e]. Among various proteases, which cause ECM degradation, matrix metalloproteinase-2 is the most significant in oral cancer [\u003ca href=\"#B26\"\u003e26\u003c/a\u003e]. Previous studies investigated the clinical significance of MMP-2 in different races with oral cancer. Immunohistochemical results indicated that MMP-2 expression significantly elevated in malignant tissues as compared with adjacent normal tissues. MMP-2 overexpression positively correlated with lymph node metastasis [\u003ca href=\"#B27\"\u003e27\u003c/a\u003e, \u003ca href=\"#B28\"\u003e28\u003c/a\u003e]. The activation ratio of MMP-2 was higher in the malignant tissues of patients with lymph node metastasis as compared with those without lymph node metastasis [\u003ca href=\"#B29\"\u003e29\u003c/a\u003e]. OSCC invasion and metastasis represent major obstacles to treatment. Thus, inhibition of metastasis of OSCC by CAPE could provide important preventive and therapeutic benefitsagainst oral cancer.\u003c/p\u003e\u003cp\u003eThe result of this studys showed that CAPE significantly inhibited the migratory/invasive ability of SCC-9 cancer cells, downregulated MMP-2 protein expression, and inhibited MMP-2 enzymatic activity. However, our data also indicated that the secreted concentrations of MMP-9 from SCC-9 cells were quite low (data not shown). The function of the MMP in vivo is dependent on the local balance between them and their natural inhibitors [\u003ca href=\"#B30\"\u003e30\u003c/a\u003e]. The TIMPs are physiological inhibitors that bind MMP in a 1:1 stoichiometry. Several studies have suggested that measuring the protease/protease inhibitor ratio in some tumors can provide an exact reflection of ECM remolding [\u003ca href=\"#B31\"\u003e31\u003c/a\u003e]. However, the relationship between metastasis and TIMP-2 remains controversial. In previous studies, TIMP-2 overexpression protected cancer cells from apoptosis and reduced cell invasion in various tumor cell lines [\u003ca href=\"#B32\"\u003e32\u003c/a\u003e, \u003ca href=\"#B33\"\u003e33\u003c/a\u003e]. In other clinical analyses, TIMP-2 expression was positively associated with tumor recurrence [\u003ca href=\"#B34\"\u003e34\u003c/a\u003e]. Our data suggested a role for TIMP-2 in the prevention of tumor cell invasion because its expression is upregulated in CAPE-treated SCC-9 cells. \u003c/p\u003e\u003cp\u003ePrevious studies have well established the role of the Mitogen-activated protein kinase (MAPK) pathway in the regulation of MMP expression and metastasis of tumor cells [\u003ca href=\"#B35\"\u003e35\u003c/a\u003e\u003ca href=\"#B37\"\u003e37\u003c/a\u003e]. Inhibition of p38 by SB203580 reduced the rate of migration of several cancer cells significantly [\u003ca href=\"#B38\"\u003e38\u003c/a\u003e]. In the study by Huang et al., the dominant-negative mutant of JNK inhibited the migration of human corneal epithelial cells [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. In other studies, both p38 and JNK modulated MMP-2 production in cancer cells [\u003ca href=\"#B40\"\u003e40\u003c/a\u003e\u003ca href=\"#B42\"\u003e42\u003c/a\u003e]. Our data showed that CAPE treatment inhibited p38 and JNK phosphorylation and downregulated MMP-2 expression, indicating a possible mechanism for the inhibition of MMP-2 synthesis by CAPE. The phosphoinositide-3 kinase (PI3K)/Akt signal transduction pathway is involved in MMP production and cell proliferation, survival, and migration [\u003ca href=\"#B43\"\u003e43\u003c/a\u003e]; however, our study results indicated that CAPE has nonsignificant effects on the PI3K/AKT signaling pathway.\u003c/p\u003e\u003cp\u003eIn conclusion, the result of our study suggested that CAPE partly exerts its antimetastatic effects on oral cancer cells by regulating MMP-2 expression through the inhibition of FAK and MAPK activation. Overall, these data suggest that CAPE has a potential use as a chemoagent for the prevention of oral cancer cell metastasis.\u003c/p\u003e\u003ch4 id=\"acknowledgments\"\u003eAcknowledgments\u003c/h4\u003e\u003cp\u003eThis study was supported by a research Grant from the National Science Council, Taiwan (no. NSC100-2632-B-040-001-MY3) and a research Grant from Chung Shan Medical University (no. G101N0001), Taiwan.\u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eR. H. Spiro, A. E. Alfonso, H. W. Farr, and E. W. Strong, Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging, \u003ci\u003eAmerican Journal of Surgery\u003c/i\u003e, vol. 128, no. 4, pp. 562567, 1974. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cervical%20node%20metastasis%20from%20epidermoid%20carcinoma%20of%20the%20oral%20cavity%20and%20oropharynx.%20A%20critical%20assessment%20of%20current%20staging\u0026author=R. H. Spiro\u0026author=A. E. Alfonso\u0026author=H. W. Farr\u0026author=\u0026author=E. W. Strong\u0026publication_year=1974\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eW. G. Stetler-Stevenson, L. A. Liotta, and D. E. Kleiner, Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis, \u003ci\u003eFASEB Journal\u003c/i\u003e, vol. 7, no. 15, pp. 14341441, 1993. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Extracellular%20matrix%206:%20role%20of%20matrix%20metalloproteinases%20in%20tumor%20invasion%20and%20metastasis\u0026author=W. G. Stetler-Stevenson\u0026author=L. A. Liotta\u0026author=\u0026author=D. E. Kleiner\u0026publication_year=1993\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eM. H. Chien, T. H. Ying, Y. S. Hsieh et al., Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity, \u003ci\u003eFood and Chemical Toxicology\u003c/i\u003e, vol. 50, pp. 558566, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dioscorea%20nipponica%20Makino%20inhibits%20migration%20and%20invasion%20of%20human%20oral%20cancer%20HSC-3%20cells%20by%20transcriptional%20inhibition%20of%20matrix%20metalloproteinase-2%20through%20modulation%20of%20CREB%20and%20AP-1%20activity\u0026author=M. H. Chien\u0026author=T. H. Ying\u0026author=Y. S. Hsieh et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eS. F. Yang, M. K. Chen, Y. S. Hsieh et al., Antimetastatic effects of \u003ci\u003eTerminalia catappa\u003c/i\u003e L. on oral cancer via a down-regulation of metastasis-associated proteases, \u003ci\u003eFood and Chemical Toxicology\u003c/i\u003e, vol. 48, no. 4, pp. 10521058, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.fct.2010.01.019\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antimetastatic%20effects%20of%20Terminalia%20catappa%20L.%20on%20oral%20cancer%20via%20a%20down-regulation%20of%20metastasis-associated%20proteases\u0026author=S. F. Yang\u0026author=M. K. Chen\u0026author=Y. S. Hsieh et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003eM. Egeblad and Z. Werb, New functions for the matrix metalloproteinases in cancer progression, \u003ci\u003eNature Reviews Cancer\u003c/i\u003e, vol. 2, no. 3, pp. 161174, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=New%20functions%20for%20the%20matrix%20metalloproteinases%20in%20cancer%20progression\u0026author=M. Egeblad \u0026author=Z. Werb\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eA. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian, Matrix metalloproteinases: biologic activity and clinical implications, \u003ci\u003eJournal of Clinical Oncology\u003c/i\u003e, vol. 18, no. 5, pp. 11351149, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases:%20biologic%20activity%20and%20clinical%20implications\u0026author=A. R. Nelson\u0026author=B. Fingleton\u0026author=M. L. Rothenberg\u0026author=\u0026author=L. M. Matrisian\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eM. Bj\u0026#xf6;rklund and E. Koivunen, Gelatinase-mediated migration and invasion of cancer cells, \u003ci\u003eBiochimica et Biophysica Acta\u003c/i\u003e, vol. 1755, no. 1, pp. 3769, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.bbcan.2005.03.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Gelatinase-mediated%20migration%20and%20invasion%20of%20cancer%20cells\u0026author=M. Bjrklund \u0026author=E. Koivunen\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eS. M. Ranuncolo, E. Armanasco, C. Cresta, E. B. De Kier Joffe, and L. Puricelli, Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients, \u003ci\u003eInternational Journal of Cancer\u003c/i\u003e, vol. 106, no. 5, pp. 745751, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ijc.11288\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Plasma%20MMP-9%20(92%20kDa-MMP)%20activity%20is%20useful%20in%20the%20follow-up%20and%20in%20the%20assessment%20of%20prognosis%20in%20breast%20cancer%20patients\u0026author=S. M. Ranuncolo\u0026author=E. Armanasco\u0026author=C. Cresta\u0026author=E. B. De Kier Joffe\u0026author=\u0026author=L. Puricelli\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eM. Yokoyama, K. Ochi, M. Ichimura et al., Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer, \u003ci\u003ePancreas\u003c/i\u003e, vol. 24, no. 4, pp. 344347, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1097/00006676-200205000-00004\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase-2%20in%20pancreatic%20juice%20for%20diagnosis%20of%20pancreatic%20cancer\u0026author=M. Yokoyama\u0026author=K. Ochi\u0026author=M. Ichimura et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eC. G. Sauer, A. Kappeler, M. Sp\u0026#xe4;th et al., Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients, \u003ci\u003eVirchows Archiv\u003c/i\u003e, vol. 444, no. 6, pp. 518526, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Expression%20and%20activity%20of%20matrix%20metalloproteinases-2%20and%20-9%20in%20serum,%20core%20needle%20biopsies%20and%20tissue%20specimens%20of%20prostate%20cancer%20patients\u0026author=C. G. Sauer\u0026author=A. Kappeler\u0026author=M. Spth et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eG. Bugdayci, T. Kaplan, S. Sezer et al., Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer, \u003ci\u003eExperimental Oncology\u003c/i\u003e, vol. 28, no. 2, pp. 169171, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase-9%20in%20broncho-alveolar%20lavage%20fluid%20of%20patients%20with%20non-small%20cell%20lung%20cancer\u0026author=G. Bugdayci\u0026author=T. Kaplan\u0026author=S. Sezer et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eS. D. Hong, S. P. Hong, J. I. Lee, and C. Y. Lim, Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential, \u003ci\u003eOral Oncology\u003c/i\u003e, vol. 36, no. 2, pp. 207213, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S1368-8375(99)00088-3\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Expression%20of%20matrix%20metalloproteinase-2%20and%20-9%20in%20oral%20squamous%20cell%20carcinomas%20with%20regard%20to%20the%20metastatic%20potential\u0026author=S. D. Hong\u0026author=S. P. Hong\u0026author=J. I. Lee\u0026author=\u0026author=C. Y. Lim\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eC. M. Coticchia, A. S. Curatolo, D. Zurakowski et al., Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels, \u003ci\u003eGynecologic Oncology\u003c/i\u003e, vol. 123, pp. 295300, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Urinary%20MMP-2%20and%20MMP-9%20predict%20the%20presence%20of%20ovarian%20cancer%20in%20women%20with%20normal%20CA125%20levels\u0026author=C. M. Coticchia\u0026author=A. S. Curatolo\u0026author=D. Zurakowski et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eT. S. Wong, D. L. W. Kwong, J. S. T. Sham, W. I. Wei, Y. L. Kwong, and A. P. W. Yuen, Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma, \u003ci\u003eEuropean Journal of Surgical Oncology\u003c/i\u003e, vol. 30, no. 5, pp. 560564, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ejso.2004.02.007\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Clinicopathologic%20significance%20of%20plasma%20matrix%20metalloproteinase-2%20and%20-9%20levels%20in%20patients%20with%20undifferentiated%20nasopharyngeal%20carcinoma\u0026author=T. S. Wong\u0026author=D. L. W. Kwong\u0026author=J. S. T. Sham\u0026author=W. I. Wei\u0026author=Y. L. Kwong\u0026author=\u0026author=A. P. W. Yuen\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eN. Song, H. Sung, J. Y. Choi et al., Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women, \u003ci\u003eCancer Epidemiology, Biomarkers \u0026#x26; Prevention\u003c/i\u003e, vol. 21, pp. 13711380, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Preoperative%20serum%20levels%20of%20matrix%20metalloproteinase-2%20(MMP-2)%20and%20survival%20of%20breast%20cancer%20among%20Korean%20women\u0026author=N. Song\u0026author=H. Sung\u0026author=J. Y. Choi et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eJ. W. Dobrowolski, S. B. Vohora, K. Sharma, S. A. Shah, S. A. H. Naqvi, and P. C. Dandiya, Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products, \u003ci\u003eJournal of Ethnopharmacology\u003c/i\u003e, vol. 35, no. 1, pp. 7782, 1991. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antibacterial,%20antifungal,%20antiamoebic,%20antiinflammatory%20and%20antipyretic%20studies%20on%20propolis%20bee%20products\u0026author=J. W. Dobrowolski\u0026author=S. B. Vohora\u0026author=K. Sharma\u0026author=S. A. Shah\u0026author=S. A. H. Naqvi\u0026author=\u0026author=P. C. Dandiya\u0026publication_year=1991\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003eP. Michaluart, J. L. Masferrer, A. M. Carothers et al., Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 59, no. 10, pp. 23472352, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibitory%20effects%20of%20caffeic%20acid%20phenethyl%20ester%20on%20the%20activity%20and%20expression%20of%20cyclooxygenase-2%20in%20human%20oral%20epithelial%20cells%20and%20in%20a%20rat%20model%20of%20inflammation\u0026author=P. Michaluart\u0026author=J. L. Masferrer\u0026author=A. M. Carothers et al.\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eO. K. Mirzoeva, P. Yaqoob, K. A. Knox, and P. C. Calder, Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis, \u003ci\u003eFEBS Letters\u003c/i\u003e, vol. 396, no. 2-3, pp. 266270, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/0014-5793(96)01111-8\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20ICE-family%20cysteine%20proteases%20rescues%20murine%20lymphocytes%20from%20lipoxygenase%20inhibitor-induced%20apoptosis\u0026author=O. K. Mirzoeva\u0026author=P. Yaqoob\u0026author=K. A. Knox\u0026author=\u0026author=P. C. Calder\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eY. Lee, D. H. Shin, J. H. Kim et al., Caffeic acid phenethyl ester-mediated Nrf2 activation and I\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB kinase inhibition are involved in NF\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB inhibitory effect: structural analysis for NF\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB inhibition, \u003ci\u003eEuropean Journal of Pharmacology\u003c/i\u003e, vol. 643, no. 1, pp. 2128, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ejphar.2010.06.016\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester-mediated%20Nrf2%20activation%20and%20IB%20kinase%20inhibition%20are%20involved%20in%20NFB%20inhibitory%20effect:%20structural%20analysis%20for%20NFB%20inhibition\u0026author=Y. Lee\u0026author=D. H. Shin\u0026author=J. H. Kim et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eW. K. Jung, D. Y. Lee, Y. H. Choi et al., Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma, \u003ci\u003eLife Sciences\u003c/i\u003e, vol. 82, no. 13-14, pp. 797805, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.lfs.2008.01.014\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester%20attenuates%20allergic%20airway%20inflammation%20and%20hyperresponsiveness%20in%20murine%20model%20of%20ovalbumin-induced%20asthma\u0026author=W. K. Jung\u0026author=D. Y. Lee\u0026author=Y. H. Choi et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eC. P. Chuu, H. P. Lin, M. F. Ciaccio et al., Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks, \u003ci\u003eCancer Prevention Research\u003c/i\u003e, vol. 5, pp. 788797, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Caffeic%20acid%20phenethyl%20ester%20suppresses%20the%20proliferation%20of%20human%20prostate%20cancer%20cells%20through%20inhibition%20of%20p70S6K%20and%20Akt%20signaling%20networks\u0026author=C. P. Chuu\u0026author=H. P. Lin\u0026author=M. F. Ciaccio et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B22\"\u003eY. T. Lee, M. J. Don, P. S. Hung et al., Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells, \u003ci\u003eCancer Letters\u003c/i\u003e, vol. 223, no. 1, pp. 1925, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.canlet.2004.09.048\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cytotoxicity%20of%20phenolic%20acid%20phenethyl%20esters%20on%20oral%20cancer%20cells\u0026author=Y. T. Lee\u0026author=M. J. Don\u0026author=P. S. Hung et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B23\"\u003eM. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki, caffeic acid phenethyl ester induces apoptosis by inhibition of\r\nNFkappaB and activation of Fas in human breast cancer MCF-7 cells, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 279, no. 7, pp. 60176026, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M306040200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=caffeic%20acid%20phenethyl%20ester%20induces%20apoptosis%20by%20inhibition%20of\r\nNFkappaB%20and%20activation%20of%20Fas%20in%20human%20breast%20cancer%20MCF-7%20cells\u0026author=M. Watabe\u0026author=K. Hishikawa\u0026author=A. Takayanagi\u0026author=N. Shimizu\u0026author=\u0026author=T. Nakaki\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B24\"\u003eT. Ramqvist and T. Dalianis, Oropharyngeal cancer epidemic and human papillomavirus, \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 16, no. 11, pp. 16711677, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3201/eid1611.100452\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Oropharyngeal%20cancer%20epidemic%20and%20human%20papillomavirus\u0026author=T. Ramqvist \u0026author=T. Dalianis\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B25\"\u003eL. M. Coussens and Z. Werb, Matrix metalloproteinases and the development of cancer, \u003ci\u003eChemistry and Biology\u003c/i\u003e, vol. 3, no. 11, pp. 895904, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinases%20and%20the%20development%20of%20cancer\u0026author=L. M. Coussens \u0026author=Z. Werb\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B26\"\u003eM. H. Chien, C. W. Lin, C. W. Cheng, Y. C. Wen, and S. F. Yang, Matrix metalloproteinase (MMP)-2 as a target for head and neck cancer therapy, \u003ci\u003eExpert Opinion on Therapeutic Targets\u003c/i\u003e. In press. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Matrix%20metalloproteinase%20(MMP)-2%20as%20a%20target%20for%20head%20and%20neck%20cancer%20therapy\u0026author=M. H. Chien\u0026author=C. W. Lin\u0026author=C. W. Cheng\u0026author=Y. C. Wen\u0026author=\u0026author=S. F. Yang\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B27\"\u003eA. Katayama, N. Bandoh, K. Kishibe et al., Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis, \u003ci\u003eClinical Cancer Research\u003c/i\u003e, vol. 10, no. 2, pp. 634640, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/1078-0432.CCR-0864-02\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Expressions%20of%20matrix%20metalloproteinases%20in%20early-stage%20oral%20squamous%20cell%20carcinoma%20as%20predictive%20indicators%20for%20tumor%20metastases%20and%20prognosis\u0026author=A. Katayama\u0026author=N. Bandoh\u0026author=K. Kishibe et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B28\"\u003eS. Kurahara, M. Shinohara, T. Ikebe et al., Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis, \u003ci\u003eHead \u0026#x26; Neck\u003c/i\u003e, vol. 21, pp. 627638, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Expression%20of%20MMPS,%20MT-MMP,%20and%20TIMPs%20in%20squamous%20cell%20carcinoma%20of%20the%20oral%20cavity:%20correlations%20with%20tumor%20invasion%20and%20metastasis\u0026author=S. Kurahara\u0026author=M. Shinohara\u0026author=T. Ikebe et al.\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B29\"\u003eH. Qin, Y. Sun, and E. N. Benveniste, The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 274, no. 41, pp. 2913029137, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.274.41.29130\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20transcription%20factors%20Sp1,%20Sp3,%20and%20AP-2%20are%20required%20for%20constitutive%20matrix%20metalloproteinase-2%20gene%20expression%20in%20astroglioma%20cells\u0026author=H. Qin\u0026author=Y. Sun\u0026author=\u0026author=E. N. Benveniste\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B30\"\u003eP. A. M. Snoek-van Beurden and J. W. Von Den Hoff, Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors, \u003ci\u003eBioTechniques\u003c/i\u003e, vol. 38, no. 1, pp. 7383, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Zymographic%20techniques%20for%20the%20analysis%20of%20matrix%20metalloproteinases%20and%20their%20inhibitors\u0026author=P. A. M. Snoek-van Beurden \u0026author=J. W. Von Den Hoff\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B31\"\u003eR. K. Nuttall, C. J. Pennington, J. Taplin et al., Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells, \u003ci\u003eMolecular Cancer Research\u003c/i\u003e, vol. 1, no. 5, pp. 333345, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Elevated%20membrane-type%20matrix%20metalloproteinases%20in%20gliomas%20revealed%20by%20profiling%20proteases%20and%20inhibitors%20in%20human%20cancer%20cells\u0026author=R. K. Nuttall\u0026author=C. J. Pennington\u0026author=J. Taplin et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B32\"\u003eS. Imren, D. B. Kohn, H. Shimada, L. Blavier, and Y. A. DeClerck, Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 56, no. 13, pp. 28912895, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Overexpression%20of%20tissue%20inhibitor%20of%20metalloproteinases-2%20by%20retroviral-mediated%20gene%20transfer%20in%20vivo%20inhibits%20tumor%20growth%20and%20invasion\u0026author=S. Imren\u0026author=D. B. Kohn\u0026author=H. Shimada\u0026author=L. Blavier\u0026author=\u0026author=Y. A. DeClerck\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B33\"\u003eP. Valente, G. Fassina, A. Melchiori et al., TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis, \u003ci\u003eInternational Journal of Cancer\u003c/i\u003e, vol. 75, pp. 246253, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=TIMP-2%20over-expression%20reduces%20invasion%20and%20angiogenesis%20and%20protects%20B16F10%20melanoma%20cells%20from%20apoptosis\u0026author=P. Valente\u0026author=G. Fassina\u0026author=A. Melchiori et al.\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B34\"\u003eD. W. Visscher, M. H\u0026#xf6;yhty\u0026#xe4;, S. K. Ottosen et al., Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence, \u003ci\u003eInternational Journal of Cancer\u003c/i\u003e, vol. 59, no. 3, pp. 339344, 1994. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ijc.2910590308\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Enhanced%20expression%20of%20tissue%20inhibitor%20of%20metalloproteinase-2%20(TIMP-2)%20in%20the%20stroma%20of%20breast%20carcinomas%20correlates%20with%20tumor%20recurrence\u0026author=D. W. Visscher\u0026author=M. Hyhty\u0026author=S. K. Ottosen et al.\u0026publication_year=1994\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B35\"\u003eP. N. Chen, Y. S. Hsieh, H. L. Chiou, and S. C. Chu, Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways, \u003ci\u003eChemico-Biological Interactions\u003c/i\u003e, vol. 156, no. 2-3, pp. 141150, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.cbi.2005.08.005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Silibinin%20inhibits%20cell%20invasion%20through%20inactivation%20of%20both%20PI3K-Akt%20and%20MAPK%20signaling%20pathways\u0026author=P. N. Chen\u0026author=Y. S. Hsieh\u0026author=H. L. Chiou\u0026author=\u0026author=S. C. Chu\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B36\"\u003eY. S. Hsieh, S. C. Chu, S. F. Yang, P. N. Chen, Y. C. Liu, and K. H. Lu, Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2, \u003ci\u003eCarcinogenesis\u003c/i\u003e, vol. 28, no. 5, pp. 977987, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/carcin/bgl221\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Silibinin%20suppresses%20human%20osteosarcoma%20MG-63%20cell%20invasion%20by%20inhibiting%20the%20ERK-dependent%20c-Jun/AP-1%20induction%20of%20MMP-2\u0026author=Y. S. Hsieh\u0026author=S. C. Chu\u0026author=S. F. Yang\u0026author=P. N. Chen\u0026author=Y. C. Liu\u0026author=\u0026author=K. H. Lu\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B37\"\u003eC. J. Weng, C. F. Chau, Y. S. Hsieh, S. F. Yang, and G. C. Yen, Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and AP-1, \u003ci\u003eCarcinogenesis\u003c/i\u003e, vol. 29, no. 1, pp. 147156, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/carcin/bgm261\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Lucidenic%20acid%20inhibits%20PMA-induced%20invasion%20of%20human%20hepatoma%20cells%20through%20inactivating%20MAPK/ERK%20signal%20transduction%20pathway%20and%20reducing%20binding%20activities%20of%20NF-B%20and%20AP-1\u0026author=C. J. Weng\u0026author=C. F. Chau\u0026author=Y. S. Hsieh\u0026author=S. F. Yang\u0026author=\u0026author=G. C. Yen\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B38\"\u003eC. Huang, K. Jacobson, and M. D. Schaller, MAP kinases and cell migration, \u003ci\u003eJournal of Cell Science\u003c/i\u003e, vol. 117, no. 20, pp. 46194628, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1242/jcs.01481\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=MAP%20kinases%20and%20cell%20migration\u0026author=C. Huang\u0026author=K. Jacobson\u0026author=\u0026author=M. D. Schaller\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B39\"\u003eZ. Huang, D. P. Yan, and B. X. Ge, JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin, \u003ci\u003eCellular Signalling\u003c/i\u003e, vol. 20, no. 11, pp. 20022012, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.cellsig.2008.07.014\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=JNK%20regulates%20cell%20migration%20through%20promotion%20of%20tyrosine%20phosphorylation%20of%20paxillin\u0026author=Z. Huang\u0026author=D. P. Yan\u0026author=\u0026author=B. X. Ge\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B40\"\u003eO. Fromigu\u0026#xe9;, Z. Hamidouche, and P. J. Marie, Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 283, no. 45, pp. 3054930556, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M801436200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Blockade%20of%20the%20RhoA-JNK-c-Jun-MMP2%20cascade%20by%20atorvastatin%20reduces%20osteosarcoma%20cell%20invasion\u0026author=O. Fromigu\u0026author=Z. Hamidouche\u0026author=\u0026author=P. J. Marie\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B41\"\u003eJ. Zhong, M. M. C. Gencay, L. Bubendorf et al., ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells, \u003ci\u003eJournal of Cellular Physiology\u003c/i\u003e, vol. 207, no. 2, pp. 540552, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/jcp.20605\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=ERK1/2%20and%20p38%20MAP%20kinase%20control%20MMP-2,%20MT1-MMP,%20and%20TIMP%20action%20and%20affect%20cell%20migration:%20a%20comparison%20between%20mesothelioma%20and%20mesothelial%20cells\u0026author=J. Zhong\u0026author=M. M. C. Gencay\u0026author=L. Bubendorf et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B42\"\u003eB. Kumar, S. Koul, J. Petersen et al., p38 Mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity, \u003ci\u003eCancer Research\u003c/i\u003e, vol. 70, no. 2, pp. 832841, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/0008-5472.CAN-09-2918\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=p38%20Mitogen-activated%20protein%20kinase-driven%20MAPKAPK2%20regulates%20invasion%20of%20bladder%20cancer%20by%20modulation%20of%20MMP-2%20and%20MMP-9%20activity\u0026author=B. Kumar\u0026author=S. Koul\u0026author=J. Petersen et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B43\"\u003eT. Tian, K. J. Nan, H. Guo et al., PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway, \u003ci\u003eOncology Reports\u003c/i\u003e, vol. 23, no. 6, pp. 15931600, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3892/or\u0026amp;#x5f;00000800\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=PTEN%20inhibits%20the%20migration%20and%20invasion%20of%20HepG2%20cells%20by%20coordinately%20decreasing%20MMP%20expression%20via%20the%20PI3K/Akt%20pathway\u0026author=T. Tian\u0026author=K. J. Nan\u0026author=H. Guo et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright \u0026#xa9; 2012 Chih-Yu Peng et al. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"materials-and-methods","title":"Materials and Methods"},{"hash":"results","title":"Results"},{"hash":"discussion","title":"Discussion"},{"hash":"acknowledgments","title":"Acknowledgments"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/ecam/2012/732578.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/ecam/2012/732578.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/ecam/2012/732578.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/ecam/2012/732578.xml"}]}],"articleStats":{"no_of_views":1730,"no_of_downloads":1123,"no_of_citations":35},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":[],"MODERATE":[],"LOW":["A \u003cb\u003eCorrigendum\u003c/b\u003e for this article has been published.\n  To view the article details, please click the Corrigendum tab above."]}},"year":"2012","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/ecam/2012/732578/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/ecam/2012/732578/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"cpr9K8AjZYaP4CWVbtn5c","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js"></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" async=""></script><script src="https://www.hindawi.com/static/themes/hindawi/base.js"></script></body></html>